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ABSTRACT 
Recombinant protein therapeutics are widely used to treat life-threatening 
diseases including cancer. Chinese hamster ovary (CHO) cells have been used for over 25 
years in the biopharmaceutical industry to produce recombinant protein therapeutics, 
where CHO cells produce almost one in three of the manufactured recombinant protein 
therapeutics. CHO cell lines are the preferred host for protein expression due to their 
ability to produce human-compatible protein glycosylation, mediate protein folding, ease 
of culturing in large-scale bioreactors and protein expression stability. However, the 
protein titers are only 5-10 g/L, leading to high market prices of the biopharmaceuticals. 
Understanding of CHO cells in the bioprocessing industry has heavily relied on empirical 
characterization with a limited knowledge of the molecular dynamics. Transcriptomics is 
one such medium through which cellular mechanisms could be better understood by 
measuring gene expression. Moreover, with the recent establishment of both Chinese 
hamster and CHO-K1 cell line genome assemblies, it is now possible to leverage these 
genomic resources to better understand and further improve CHO cell bioprocessing. The 
information obtained from the comprehensive transcriptome analysis can be leveraged to 
engineer CHO cells with desired phenotypes including high protein titers and used to 
control the bioreactor environment to reduce waste production. This dissertation work 
harnessed the capabilities of next-generation transcriptomic technique, RNA-seq, to 
quantify the gene expression changes in CHO cells under several industrially relevant 
treatments including changes due to the adaptation of CHO cells to serum-free media, 
low temperature, low pH and medium glucose concentration. 
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Like most mammalian cells, parental CHO cell lines are grown as adherent cells 
in serum supplemented medium. Due to regulatory issues about the use of serum, CHO 
cells are grown as suspension cells in serum-free medium in large industrial bioreactors. 
However, CHO cell lines have to be adapted to serum-free medium, prior to large-scale 
cultivation. Adaptation of CHO cells to serum-free medium is a tedious, time-consuming 
process and can lead to complications such as cell cycle arrest and cell death in CHO 
cells undergoing adaptation process. In order to characterize the serum-free adaptation 
process, we adapted a parental cell line, CHO DHFR-, and a recombinant cell line, rCHO 
DP-12, from a serum-containing medium to a serum-free, protein-free chemically defined 
medium. The recombinant rCHO DP-12 cell line adapted to the serum-free media in 
about two months, while the CHO DHFR- cells only partially adapted to serum-free 
medium. For transcriptome analysis, RNA samples from the two cell lines were taken 
from different serum-free adaptation stages. The transcriptome analysis was used to 
evaluate the impact of serum-free medium adaptation process on glycosylation, cell cycle 
and apoptosis related genes. Additionally, the gene expression differences between the 
recombinant and non-recombinant CHO cell lines during the adaptation process were 
investigated to address the varying adaptation behavior among it.  
Often times in the biopharmaceutical industry, culture longevity and protein 
productivity are improved by shifting the cells to a lower process temperature. 
Alternatively, CHO cells cultured at a lower pH than typical pH values have been 
observed to improve cell viability, lower waste production (such as lactate) and enhance 
recombinant protein yield. Unfortunately, the impact of lower culture temperature and pH 
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is highly cell line and recombinant protein specific. To understand the impact of low 
temperature (33°C) and low pH on CHO cell transcriptome, RNA samples from two 
CHO cell lines – a non-recombinant cell line CHO K1-PF and a recombinant cell line 
CHO DP-12 at different conditions were harvested and sequenced. However, the impact 
of culture pH on CHO cell transcriptome was found to be minimal in this work. 
Differential gene expression analysis identified 3,186 genes significantly impacted by 
temperature in both CHO cell lines. Genes related to DNA replication, DNA repair and 
translation were sensitive to temperature and had lower expression at 33°C. Additionally, 
glycosylation related genes such as Slc35d1 and Slc35d2, which are involved in the 
transport of nucleotide sugars, were found to have higher expression at lower 
temperatures. 
For most mammalian cell lines, glucose serves as the primary carbon 
source required for growth and maintenance. Glucose metabolism is also central to 
several key intermediates for the synthesis of cellular components such as lipids, sugar 
chains and nucleic acids are generated during glycolysis. However, incomplete oxidation 
of glucose can lead to lactate production and inefficient low energy. Typically, 
mammalian cell culture media contain glucose concentrations ranging from 25 mM to 35 
mM (~4.5 g/L to 6.5 g/L). Glucose concentrations above 10 mM are analogous to 
diabetic levels of glucose in humans, suggesting that the mammalian cells are cultivated 
in excess glucose. Alternatively, maintaining low glucose concentrations (~ 5mM) has 
been attempted to reduce the glucose intake by mammalian cells. The effects of 
extracellular glucose concentration (30 mM or 10 mM) on the transcriptome of rCHO 
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DP-12 cells producing monoclonal antibody were investigated. Only 575 genes were 
identified as significantly different (FDR ≤ 0.01). Moreover, gene expression analysis 
revealed that no notable changes in glycolysis, TCA cycle or glycosylation genes were 
observed in CHO cell cultured under different glucose concentrations. These expression 
studies indicated that low glucose concentration batch medium for fed-batch CHO cell 
cultures has potential to improve processes by reducing waste accumulation without 
impacting process related genes. 
Overall, the transcriptome studies exploited the availability of recent 
Chinese hamster genome data to gain insights into the impact of industrially relevant 
treatments on CHO cells. The data obtained from these studies could be utilized to dictate 
improvements in cell line engineering and media development to further improve 
production processes. 
vi 
DEDICATION 
This work is dedicated to all my family members, my parents - Mr. Gowtham 
Chand and Mrs. Chandra Kumari, my brother - Mr. Hithender Kumar, my sister-in-law 
Mrs. Preethi, the little men, my newphews – Mr. Yashveer and Mr. Priyank, and last but 
by no means least, my loving wife - Mrs. Aishwarya Vaidyanathan. Their unconditional 
love and support have made me the person I am today and this journey would not have 
been possible without them.  
vii 
ACKNOWLEDGMENTS 
First and foremost, I would like to thank my guru Dr. Sarah Harcum for her 
invaluable guidance and shaping my scientific thinking. I’m eternally grateful for her 
relentless support and her belief in me throughout my time at graduate school. I would 
like to thank my committee members, Dr. Christopher Saski, Dr. Delphine Dean and Dr. 
Melinda Harman. I would like to thank them for their time and patience during the 
several discussions, which were critical for the development of my ideas. I want to extend 
my thanks towards Clemson University Genomics Institute and specifically towards Mrs. 
Barbara Blackmon, Mrs. Xin Xie (Penny) and Dr. Rooksana Noorai for their invaluable 
support throughout this project. I would like to extent my gratitude towards Dr. Upendra 
Kumar Devisetty, who spent countless hours helping me write code for edgeR. I’m 
appreciative of the support I had from my lab members – Mr. Tom Caldwell, Dr. Kristen 
Miller, Dr. Arthur Brodsky and Mr. Daniel Odenwelder, at several instances throughout 
my time at Clemson. I would like to thank my dear friends – Srikanth Sivaraman, Karthik 
Gopalakrishnan and Sriram Sankar, who have been central to my personal growth at 
Clemson. Maria Martin deserves a special mention for her welcoming attitude and 
unbelievable willingness to help me. Last but not least, I’m thankful to the department of 
Bioengineering for this opportunity and various funding sources for their financial 
support through my graduate studies– National Science Foundation (CBET 1218345) and 
Department of Energy (DE-FG36-086088071). 
viii 
TABLE OF CONTENTS 
Page 
TITLE PAGE .................................................................................................................... i 
ABSTRACT ..................................................................................................................... ii 
DEDICATION ................................................................................................................ vi 
ACKNOWLEDGMENTS ............................................................................................. vii 
LIST OF TABLES ........................................................................................................... x 
LIST OF FIGURES ....................................................................................................... xii 
CHAPTER 
I. INTRODUCTION........................................................................................ 1
1.1 Motivation ................................................................................................ 1 
1.2 Organization ............................................................................................. 3 
II. LITERATURE REVIEW ........................................................................... 4 
2.1 Chinese hamster ovary cells..................................................................... 4 
2.2 Transcriptomics........................................................................................ 8 
2.3 CHO Bioprocessing Studies .................................................................. 12 
2.3.1 Serum-free medium adaptation in CHO cells ............................... 12 
2.3.2 Temperature studies ...................................................................... 16 
2.3.3 pH studies...................................................................................... 19 
2.3.4 Glucose studies ............................................................................. 22 
III. TRANSCRIPTOME-WIDE PROFILING OF CHINESE HAMSTER
OVARY (CHO) CELL LINES USING RNA-SEQ TO IDENTIFY
CRITICAL GENE EXPRESSION BOTTLENECKS IN SERUM-FREE
MEDIUM ADAPTATION PROCESS ..................................................... 26 
ix 
3.1 Abstract .................................................................................................. 26 
3.2 Introduction ............................................................................................ 28 
3.3 Materials and Methods ........................................................................... 32 
3.4 Results and Discussion .......................................................................... 38 
3.5 Conclusions ............................................................................................ 76 
IV. IMPACT OF LOW CULTURE TEMPERATURE AND LOW INITIAL
MEDIA PH ON CHINESE HAMSTER OVARY (CHO) CELL LINES:
A TRANSCRIPTOMIC PERSPECTIVE USING RNA-SEQ ............... 78 
4.1 Abstract .................................................................................................. 78 
4.2 Introduction ............................................................................................ 80 
4.3 Materials and Methods ........................................................................... 83 
4.4 Results and Discussion .......................................................................... 88 
4.5 Conclusions .......................................................................................... 115 
V. ASSESSING THE IMPACT OF EXCESSIVE MEDIA GLUCOSE
CONCENTRATIONS ON RECOMBINANT CHINESE HAMSTER
OVARY (CHO) CELL TRANSCRIPTOME USING RNA-SEQ ....... 116 
5.1 Abstract ................................................................................................ 116 
5.2 Introduction .......................................................................................... 118 
5.3 Materials and Methods ......................................................................... 121 
5.4 Results and Discussion ........................................................................ 126 
5.5 Conclusions .......................................................................................... 141 
VI. CONCLUSIONS AND FUTURE WORK ............................................. 142 
APPENDICES ............................................................................................................. 144 
A: Filtering of RNA-seq raw counts ............................................................... 145 
B: MDS Plots .................................................................................................. 150 
C: Corrected glycosylation gene list ............................................................... 154 
REFERENCES ............................................................................................................ 162 
Table of Contents (Continued)     
 Page 
x 
 
LIST OF TABLES 
 
 
Table                                                                                                                               Page 
 
 3.1 Pairwise comparisons of rCHO DP-12 and CHO DHFR- between the cell lines 
and different serum concentrations (FDR ≤ 0.01) ....................................... 45 
 
 3.2 Glycosylation-related genes sensitive to serum-free medium adaptation 
process.......................................................................................................... 48 
 
 3.3 Cell cycle-related genes sensitive to serum-free medium 
  adaptation process ........................................................................................ 55 
 
 3.4 Apoptosis-related genes sensitive to serum-free medium  
  adaptation process ........................................................................................ 60 
 
 3.5 Enriched GO terms for genes sensitive in rCHO DP-12 only ..................... 65 
 
 3.6 Enriched GO terms for significant genes between rCHO DP-12 and CHO K1-
PF during the transition from 10% serum to 5% serum............................... 69 
 
 3.7 Enriched GO terms among genes with expression differences between rCHO 
DP-12 and CHO K1-PF during the transition from 10%  
  serum to 5% serum....................................................................................... 74 
 
 4.1 Growth rates for all rCHO DP-12 and CHO K1-PF cultures grown at different 
culture temperature and different initial media pH. ..................................... 90 
 
 4.2 Pairwise comparisons of rcHO DP-12 and CHO K1-PF cultured at different 
temperatures and initial media pH (FDR ≤ 0.01). There were 11,016 genes 
using for the comparison. Numbers in parenthesis indicated the number of 
genes with greater than 1.5-fold change in expression ................................ 96 
 
 4.3 Pairwise comparisons of rCHO DP-12 and CHO K1-PF cultured at different 
temperatures (FDR ≤ 0.01). There were 11,016 genes using for the 
comparison. Numbers in parenthesis indicated the number of genes with 
greater tan 1.5-fold change in expression. The numbers in bold represent 
comparisons with temperature as the main factor and the numbers in italics 
represent comparisons with cell line as the main factor. ............................. 97 
 
 4.4 Glycosylation genes that were temeprature sensitive with more than 1.5-fold 
change in both rCHO DP-12 and CHO K1-PF (FDR ≤ 0.01) ................... 101 
 
xi 
 
List of Tables (Continued) 
 
Table                                                                                                                               Page 
 
 4.5 Cell cycle genes with more than 1.5-fold change that were temperature 
sensitive in both rCHO DP-12 and CHO K1-PF ....................................... 105 
 
 4.6 Apoptosis genes with more than 1.5-fold change that were temperature 
sensitive in both rCHO DP-12 and CHO K1-PF ....................................... 109 
 
 4.7 Enriched GO terms among the common temperature sensitive genes in rCHO 
DP-12 and CHO K1-PF (FDR ≤ 0.01)....................................................... 111 
 
 5.1 Enriched significant genes in CHO cells cultured in low glucose medium 
(FDR ≤ 0.01) .............................................................................................. 132 
 
 5.2 Enriched GO terms among the common temperature sensitive genes in rCHO 
DP-12 and CHO K1-PF (FDR ≤ 0.01)....................................................... 135 
 
 5.3 Glycolysis and TCA cycle gene expression in rCHO DP-12 cultured in low 
glucose relative to the high glucose medium ............................................. 138 
 
 5.4 Protein glycosylation genes that were sensitive to external glucose 
concentration .............................................................................................. 141 
 
 C.1 Corrected glycosylation gene list ............................................................... 154 
xii 
 
LIST OF FIGURES 
 
 
Figure                                                                                                                             Page 
 
 2.1 Lineage of CHO cell lines since its isolation in 1957. ................................... 5 
 
 2.2 Adaptation of several CHO cell lines to serum-free media ......................... 15 
 
 2.3 Simplified glycolysis and tricarboxylic acid (TCA) cycle showing basic 
glucose metabolism. ..................................................................................... 23 
 
 3.1 Serum-free medium adaptation timelines of the two CHO cell lines, rCHO 
DP-12 and CHO DHFR-, used in this study ................................................ 40 
 
 3.2 Growth profiles of rCHO DP-12 and CHO DHFR- cell lines at 10%, 5% and 
0% serum media. .......................................................................................... 42 
 
 3.3 Venn diagram of three pairwise comparisons with serum  
  as the main effect ......................................................................................... 46 
 
 3.4 Glycosylation genes significantly impacted by the serum-free medium 
adaptation process in rCHO DP-12 and CHO DHFR- (FDR ≤ 0.01).. ........ 53 
 
 3.5 Cell cycle genes sensitive to serum-free medium adaptation process – A) 
cyclin dependent kinase inhibitors and B) cyclins and cyclin-dependent 
kinases. ......................................................................................................... 57 
 
 3.6 Apoptosis related genes that were affected by serum-free medium adaptation 
process.......................................................................................................... 62 
 
 3.7 Rab43 and Rras gene expression in rCHO DP-12 and CHO DHFR-. ......... 66 
 
 3.8 Glutathione peroxidase genes in rCHO DP-12 (open) and CHO DHFR- 
(closed) during the serum-free medium adaptation process ........................ 70 
 
 3.9 Differences in expression DNA replication related genes between rCHO DP-
12 and CHO K1-PF ...................................................................................... 75 
 
 4.1 Growth profiles for all rCHO DP-12 and CHO K1-PF cultures. Black circles 
indicate the time at which RNA samples were harvested ............................ 91 
xiii 
List of Figures (Continued) 
Figure       Page 
4.2 Glucose and lactate concentration profiles for rCHO DP-12 and CHO K1-PF 
cultures ......................................................................................................... 92
4.3 Commonly affected A) higher expression and B) lower expression 
temperature sensitive genes between rCHO DP-12 and  
CHO DHFR-................................................................................................. 95 
4.4 Normalized expression levels of sialidase genes – Neu1, Neu2 and Neu3 in 
rCHO DP-12 and CHO K1-PF cultured at 33°C and 37°C ....................... 102 
4.5 Normalized expression levels of nucleotide sugar transporters A) Slc35d1 and 
B) Slc35d2 in rCHO DP-12 and CHO K1-PF cultured at
33°C and 37°C ........................................................................................... 103 
4.6 Cyclin-dependent kinase inhibitors (Above) and Cyclins (below) represent the 
temperature sensitive cell cycle genes in both CHO cell lines .................. 106 
5.1 Cell concentration (A), glucose (circles) and lactate profiles (squares) are 
shown for CHO cells cultured under high glucose (closed symbol) and low 
glucose (open symbol) conditions ............................................................. 127 
5.2 Distribution of significant glucose sensitive genes in rCHO DP-12 ......... 131 
A.1 Figure A1: Biological coefficient of variation (BCV) plots for CPM 1, 5, 10
(top to bottom) are an effective way to visualize the relationship of variance 
with expression .......................................................................................... 147 
A.2 Venn diagram of differentially expressed genes in rCHO DP-12 at 33°C
relative to 37°C with more than 1.5-fold cutoff between the three different 
CPM cutoff................................................................................................. 148 
A.3 Venn diagram of enriched GO terms in rCHO DP-12 cultured at low
temperature at CPM 1, CPM 5, and CPM 10 ............................................ 149 
B.1 MDS plots representing gene expression profiles of rCHO DP-12 (closed) and
CHO DHFR- (open) cultured at three different serum concentrations – 10% 
(squares), 5% serum (circles) and 0% serum (triangles). .......................... 150 
xiv 
B.2 MDS plots representing gene expression profiles of rCHO DP-12 (squares and
circles) and CHO K1-PF (triangles and diamonds) cultured at 37°C (circles 
and diamonds, respectively) and 33°C (squares and triangles, respectively) 
and at pH 6.90 (closed) and pH 6.70 (open) .............................................. 151 
B.3 MDS plot for gene expression profiles of rCHO DP-12 (closed) and CHO K1-
PF (open) at 37°C (circles) and 33°C (squares) ......................................... 152 
B.4 MDS plot for gene expression profiles of rCHO DP-12 cells in high glucose
(open) and low glucose (closed) medium .................................................. 153 
List of Figures (Continued) 
Figure       Page 
1 
CHAPTER 1 
 
INTRODUCTION 
 
 
1.1 MOTIVATION 
 
In the last twenty years, more than 230 biopharmaceuticals (also called biologics) 
have been approved by the United States Food and Drug Administration (FDA); 
furthermore there are over 200 biopharmaceuticals currently in development (Carter 
2011; Kantardjieff and Zhou 2013; Walsh 2010). These biopharmaceuticals are used to 
treat debilitating diseases such as cancer, cardiovascular diseases, and HIV/AIDS (Datta, 
et al. 2013; Walsh 2010). It has been estimated that the biologics on market have 
benefitted more than 250 million people globally (Walsh 2003). With the present 
availability of biopharmaceuticals in markets and a greater number in clinical 
development stages, the revenue generated is expected to be around $180 billion in the 
year 2016 (Bandaranayake and Almo 2013; Batra, Anurag S Rathore Jyoti 2016; Butler 
and Meneses-Acosta 2012; Carter 2011). Despite its ability to treat life-threatening 
diseases, one of the major issues associated with biopharmaceuticals are the very high 
treatment costs. For example, a treatment using a recombinant monoclonal antibody can 
cost over $100,000/year per patient. These high treatment costs have resulted in questions 
about the affordability of such treatments (Malik 2009). The high costs of these 
biopharmaceutical drugs have been partially attributed to the low amounts of protein 
produced by Chinese hamster ovary (CHO) cell cultures and the long culture times. 
Therefore, improving protein production levels in CHO cells is essential and highly 
relevant to bring down biopharmaceutical costs. In the last 30 years of the 
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biopharmaceutical industry, the improvements in CHO cell culture have been largely 
driven through empirical efforts; however, a more fundamental understanding of the 
bottlenecks in CHO cell bioprocessing is required for further advances. 
Recently, genome sequences of Chinese hamster and Chinese hamster ovary cell 
lines were established (Brinkrolf, et al. 2013; Lewis, et al. 2013; Xu, et al. 2011). The 
newly available genomic resources presents a novel range of opportunities to delve into a 
deeper understanding of Chinese hamster ovary cell lines, which was not available 
previously. These genomic data can additionally support and improve other ‘omics based 
techniques including transcriptomics. The understanding of the CHO cell gene expression 
under industrially relevant environmental conditions that are known to alter the 
productivity and product quality will facilitate better cellular level understanding that 
could be used to design/optimize improved CHO cell culture processes. Additionally, the 
findings could direct the engineering of CHO cell lines with favorable characteristics 
such as consistent glycosylation and low waste metabolite production. The data obtained 
in these studies will add to the current understanding of CHO cell responses and be a 
valuable resource to the CHO cell community. 
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1.2 ORGANIZATION 
 This dissertation is divided into six chapters. Chapter One outlines the motivation 
of for this dissertation. In Chapter Two, the literature of key topics related to this work 
has been reviewed. The history and importance of CHO cell lines, and transcriptome 
studies related to CHO cell lines have been discussed. Additionally, literature review 
related to serum-free medium adaptation, temperature and pH effects, and the impact of 
glucose with respect to CHO cell cultures are presented. The chapters Three, Four and 
Five present the main studies of this dissertation. Chapter Three describes the 
transcriptome analysis of the CHO cells undergoing serum-free medium adaptation 
process. Chapter Four describes the effects of temperature and pH on the CHO cell 
transcriptome. Chapter Five discusses the impact of glucose on gene expression levels in 
recombinant CHO cells. Finally, Chapter Six discusses future directions for this work. 
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1 Chinese Hamster Ovary Cells 
Chinese hamsters are a part of Cricetidae family and Cricetulus genus, originally 
from deserts of China and Mongolia. Chinese hamsters have been long used as laboratory 
models to investigate radiation cytogenetics, hereditary diseases and tissue cultures 
(Jayapal, et al. 2007; Yerganian 1972; Yerganian 1985). In the late 1950s, Dr. Theodore 
Puck established CHO cells from an ovary biopsy of a female Chinese hamster while 
researching somatic cell genetics (Tjio and Puck 1958). Since the isolation of the first 
CHO cell line, several CHO cell variants have been created through various selection and 
mutation methods  (Flintoff, et al. 1976; Kao and Puck 1968; Puck, et al. 1958; Tjio and 
Puck 1958; Urlaub, et al. 1983; Urlaub and Chasin 1980), of which, several are major 
biopharmaceutical cell line used in the production of recombinant therapeutic proteins 
(Figure 1). Three different CHO cell lines were used in the following dissertation work– 
a recombinant CHO cell line (rCHO DP-12 that produces an IgG against Interleukin-8) 
and two non-recombinant CHO cell lines (CHO DHFR-/CHO DUXB11 and CHO K1-
PF). CHO DHFR- is the parental host cell line of the rCHO DP-12 cells and CHO-K1 
Protein Free is the protein-free, serum-free medium adapted version of the ancestral CHO 
K1 cell line.  
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Figure 2.1: Lineage of CHO cell lines since its isolation in 1957. Green shaded boxes 
represent the CHO cell lines used in this dissertation work. Draft genome sequences are 
only available for Chinese hamster and CHO-K1 as of April 2016, as denoted by *.  
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The extensive use of CHO cell lines in the biopharmaceutical industry has been 
attributed to advantages such as being a well established expression system, ability to 
produce human-compatible proteins, can be scaled to large-scale processes, and being 
safe hosts for therapeutic protein production (Datta, et al. 2013; Jayapal, et al. 2007; Kim, 
et al. 2012). One of the industrially relevant CHO cell line, CHO DUKXB11 (CHO 
DXB11/CHO DHFR-), harbored the inactivated dihydrofolate reductase (DHFR) gene, 
which was critical for its use in industrial therapeutic protein production (Jayapal, et al. 
2007; Urlaub, et al. 1983; Urlaub and Chasin 1980; Wuest, et al. 2012). The DHFR 
enzyme is required for the synthesis of the key amino acids such as hypoxanthine and 
thymidine and CHO cells lacking the gene (DHFR-) require the supplementation of these 
amino acids in the medium. This deficiency was exploited to develop a selection system 
for recombinant CHO cells (Jayapal, et al. 2007; Wuest, et al. 2012). Furthermore, this 
system allowed the amplification of the recombinant genes through the addition of 
methotrexate (MTX), an inhibitor of DHFR activity. Another CHO cell selection system 
utilizes glutamine synthetase (GS) as a selection marker (Blochberger, et al. 1997). It is 
these selection and amplification systems that have allowed for easy manipulation and 
expression of recombinant genes in CHO cells. The other major advantage of using CHO 
cells over other rodent cell lines is in its ability to produce proteins with human-
compatible glycosylation. In fact in the transcriptomic study of CHO K1 cell line, it was 
observed that several genes coding for glycan structures, such as bisecting N-
acetylglucosamine, 1,3-galactosyltrasnferase, and N-glycolyneuramic acid, that could 
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potentially elicit immunogenic response in humans, were not expressed in CHO cells, 
despite being found in the CHO genome (Harcum 2005; Xu, et al. 2011).  
In the last few decades, CHO cell protein productivities have increased from ~ 
100 mg/L in the initial processes commissioned to about 5-10 g/L in the current processes 
(Datta, et al. 2013; Jayapal, et al. 2007; Kim, et al. 2012). These improvements were 
made possible through advances in screening and cell line development, media 
optimization, process control improvements and by employing fed-batch processes. 
However, the productivities are 10-100 fold lower than what can be achieved using 
microbial host systems (Jayapal, et al. 2007). Additional bottlenecks include 
accumulation of waste product, inconsistent glycosylation and low cell densities 
(Bandaranayake and Almo 2013; Datta, et al. 2013; Wuest, et al. 2012). These limitations 
primarily stem from inadequate understanding of CHO cells at cellular and molecular 
level. The recent establishment of parental CHO-K1 and Chinese hamster reference 
genome has opened up a new avenue for understanding CHO cells, which was not 
previously possible (Lewis, et al. 2013; Xu, et al. 2011). These genomic resources will 
provide support and improve other ‘omics technologies such as transcriptomics, 
metabolomics and proteomics. An integrated approach of these techniques is expected to 
drive next-generation CHO cell bioprocessing through an increased cellular level 
understanding of these cells. 
  
8 
 
2.2 Transcriptomics 
For an increased system level understanding of CHO cells, the use of ‘omics-
based technologies has become essential (Datta, et al. 2013; Laux 2014; Wright and Estes 
2014; Wuest, et al. 2012). ‘Omics is a broad discipline of science that analyzes the 
interaction networks of genes, proteins and metabolic enzymes (Datta, et al. 2013; Laux 
2014; Wright and Estes 2014). Specifically, transcriptomic analysis measures the 
messenger RNA content within a cell at a given time (Fu, et al. 2009; Marioni, et al. 
2008; Wang, et al. 2009). As transcriptome technologies have improved, greater fractions 
of the mRNA within a cell have become measureable (Wang, et al. 2009; Wuest, et al. 
2012). Studying the transcriptome is essential to understand genome functioning and 
comparative transcriptome analyses have been widely implemented to establish 
relationships between gene expression and its environmental conditions in several 
different organisms. To quantify and analyze the transcriptome of an organism, 
technologies have been evolved from northern blots and real-time quantitative reverse 
transcriptase polymerase chain reaction (qRT-PCR) to DNA microarrays and RNA 
sequencing (RNA-seq) (Wang, et al. 2009; Wuest, et al. 2012).  
In northern blots or qRT-PCR, a known mRNA sequence is amplified prior to 
measuring the gene expression (Wuest, et al. 2012). In contrast, DNA microarrays have 
the advantage of simultaneously probing thousands of genes hybridized on a chip. DNA 
microarray technology is one of the most powerful and widely used tools for 
transcriptome studies (Kantardjieff, et al. 2010; Klausing, et al. 2011). A newer 
alternative method for transcriptome analysis is RNA-seq, a high-throughput sequencing 
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method that directly and simultaneously sequences complementary DNA strands 
producing millions of short sequence reads (30-400 bp) (Fu, et al. 2009; Marioni, et al. 
2008; Mortazavi, et al. 2008). RNA-seq, unlike hybridization-based approaches such as 
DNA microarray, is not limited to detecting transcripts that correspond to existing 
genomic sequence (Marioni, et al. 2008; Wang, et al. 2009). RNA-Seq also provides 
complete and contiguous sequences that do not require a prior annotated sequence (Fu, et 
al. 2009; Mortazavi, et al. 2008). This is particularly useful for non-model organisms for 
which the reference genome is absent. Additionally, RNA-seq has minimal background 
noise, enabling it to detect genes with low expression, and does not have an upper limit of 
detection (Fu, et al. 2009; Wang, et al. 2009). Consequently, it has a wider detection 
range in comparison to DNA microarrays. Several studies that compared the gene 
expression results of RNA-seq and DNA microarrays concluded that RNA-seq data was 
highly reproducible and more consistent, over DNA microarrays, with the results of 
parallel quantitative methods like proteomics and qRT-PCR (Fu, et al. 2009; Marioni, et 
al. 2008). Despite the advantages, RNA-seq has been used sparingly due to high cost 
associated with it and the tools for RNA-seq data analysis and statistical analysis are still 
being refined (Fang, et al. 2012; Oshlack, et al. 2010; Rahmatallah, et al. 2014; Wang, et 
al. 2009). Confounding the transition from DNA microarray to RNA-seq analysis is a 
fundamental difference between the types of results obtained. RNA-seq provides discrete 
counts for gene expression observed in a sample, while DNA microarrays provides 
continuous intensity data representing hybridization with the target sequence (Fang, et al. 
2012). The statistical analysis of discreet data requires the use of negative binomial 
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distribution to model the mean-variance relationship, as opposed to the log-normal 
distribution used for DNA microarray based data (Anders, et al. 2013; Oshlack, et al. 
2010; Robinson and Smyth 2008; Robinson, et al. 2010; Oshlack and Wakefield 2009). 
Prior to the presence of CHO genome sequence, northern blots and qRT-PCR 
were widely used to assess the CHO cell gene expression under several bioprocessing 
conditions such as hyperosmolarity, ammonia buildup, as well as study the behavior of 
glycosylation genes in a bioreactor (Chen and Harcum 2006; Jiang and Sharfstein 2008; 
Wong, et al. 2010). However, northern blots and qRT-PCR are tedious due to the gene-
by-gene analysis and tend to be expensive per gene examined in comparison to 
microarrays and RNA-Seq (Wuest, et al. 2012). DNA microarrays provide a relative 
quantitative measurement of the transcript and has been used most extensively for 
comparative transcriptome analysis. Initial transcriptome studies of CHO cell responses 
under different cell culture conditions were assessed by incomplete CHO DNA 
microarrays and non-CHO-derived cross-species (rat or mouse) DNA microarrays due to 
unavailability of sufficient sequence information (Baik, et al. 2006; De Leon Gatti, et al. 
2007; Yee, et al. 2008). For example, comparative transcriptome analyses using CHO 
DNA microarrays have been performed under productivity enhancing conditions such as 
low temperature, high osmotic conditions and in the presence of sodium butyrate 
(Kantardjieff, et al. 2009; Klausing, et al. 2011; Yee, et al. 2009). However, DNA 
microarray has several drawbacks such as poor detection of low gene expression levels, 
cross-hybridization between similar genes, limited number of genes that can be 
hybridized on the microarray and inability to detect genes not included on the microarray. 
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Additionally studies have demonstrated the inefficiency of results generated by cross-
species microarray hybridization (Ernst, et al. 2006; Yee, et al. 2008). RNA-seq has been 
used in limited but impactful CHO transcriptome studies. In the publication of the draft 
CHO-K1 genome sequence, Xu et al. (2011) used RNA-seq to assess the transcriptome of 
CHO-K1 cells, grown in a serum-supplemented medium, to detect expression of over 
24,000 genes. One key feature of the transcriptome analysis was that several viral 
receptor genes were present in the genome but expression of these genes was not detected 
by RNA-seq. This was important in explaining the viral-resistance characteristic of CHO 
cell lines (Xu, et al. 2011). More recently, several studies have utilized RNA-Seq to 
investigate clonal stability and enhancers of protein productivity in CHO cell lines 
(Konitzer 2015, Orellana 2015, Li 2016, Veith 2016).  
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2.3 CHO Bioprocessing Studies 
Culture environmental has been well documented to influence the CHO cell 
behavior (Baik, et al. 2011; Borys, et al. 1993; Borys, et al. 1994; Furukawa and Ohsuye 
1998). Studies have observed that alterations in pH, media composition, temperature and 
dissolved oxygen directly affect CHO cell physiology, which results in growth, 
metabolism, protein yield and protein quality changes. For example, under mild 
hypothermic culture conditions CHO cells often have enhanced specific protein 
productivity (Kaufmann, et al. 1999; Yoon, et al. 2003b; Yoon, et al. 2003b; Yoon, et al. 
2005). The understanding of the impact of key environmental factors on CHO cells is 
critical to direct improvements in CHO cell bioprocessing. Often, the environmental 
parameters exert control on CHO cells at cellular and molecular levels including the gene 
expression/transcriptome (Chen and Harcum 2006; Kantardjieff, et al. 2010; Lee, et al. 
2014; Yee, et al. 2009). In this dissertation, CHO cell gene expression was characterized 
using RNA-seq during serum-free medium adaptation process, in addition to other culture 
parameters such as temperature, pH and glucose levels. The following section discusses 
CHO literature studies specific to serum-free medium adaptation process, culture 
temperature, culture pH, and glucose concentrations.  
 
2.3.1 Serum-free medium adaptation in CHO cells  
Mammalian cell culture media have been developed and refined extensively for 
over sixty years to improve cell growth and/or productivity  (Freshney 2005; Ozturk and 
Hu 2005). To support mammalian cell growth, it is common practice to supplement basal 
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cell culture medium with 10% serum (Ozturk and Hu 2005). Serum is the supernatant of 
clotted blood and is different from plasma, in that, it does not contain clotting factors. 
Serum is a complex mixture of attachment factors, growth factors, vitamins, and 
micronutrients. Fetal bovine serum (FBS) is the preferred additive over other animal sera 
due to its purity, ease of storage and growth factor content (Even, et al. 2006). However, 
animal sera, including FBS, can be a potential source of contaminants such as prions and 
viruses (Costa, et al. 2013; Gstraunthaler 2003; Rodrigues, et al. 2013; Schröder, et al. 
2004; Sinacore, et al. 2000). These potential contaminants pose regulatory concerns 
especially when the cell culture products are used for therapeutic purposes in humans. 
Additional concerns over the use of animal sera include batch variation, components 
interfering with downstream purification steps, and its undefined nature, which can 
complicate and cause inconsistency in CHO cell culture. Industrially, for aforementioned 
reasons, CHO cells are preferred to be cultured in chemically defined serum-free 
formulations (Gstraunthaler 2003; Jaluria, et al. 2008; Rasmussen, et al. 1998; Rodrigues, 
et al. 2013; Zander and Bemark 2008).  
Since CHO cells are traditionally grown in serum containing medium, they need 
to be adapted to grow in serum-free medium. However, the adaptation process is time-
consuming, tedious and not straightforward (Baik, et al. 2011; Rodrigues, et al. 2013; 
Schröder, et al. 2004; Sinacore, et al. 2000). To minimize the effects of serum 
withdrawal, CHO cells are normally adapted to serum-free medium by gradually 
lowering serum concentrations in a step-wise manner over several weeks. Sinacore et al. 
(2000) described a three-step protocol to adapt mammalian cells, in particular CHO cells, 
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to serum-free and high-density suspension cultures (Sinacore, et al. 2000). Despite this 
protocol, many research groups still have difficulties adapting CHO cells to serum-free 
medium as this process results in growth declination, disturbed cell cycle progression, 
and activation of apoptosis pathways (Sinacore, et al. 2000). Serum removal has also 
been reported to impact protein productivity and protein glycosylation quality (Costa, et 
al. 2013; Gawlitzek, et al. 1995; LeFloch, et al. 2006; Watson, et al. 1994). Figure 2.2 
shows the timeline of the adaptation process for CHO cells by several research groups, 
which highlights the long time required. Commonly, the serum-free adaptation process 
for a recombinant CHO cell lines are shorter than for non-recombinant CHO cell lines as 
shown by shorter timelines of rGS-CHO and rCHO in comparison to the adaptation 
timelines of non-recombinant CHO DUXB11 and CHO-K1. 
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Figure 2.2: Serum-free medium adaptation timelines of several CHO cell lines by 
different research groups. DUKX and DXB11 (both also known as CHO DUKXB11, 
CHO DHFR-) and CHO K1 are non-recombinant cell lines, whereas rCHO and rGS-CHO 
represent the recombinant cell lines.  
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From an ‘omics perspective, only few studies are available in literature that have 
examine the serum-free adaptation process. For instance, a recombinant CHO cell 
proteome based study identified six proteins, including heat shock proteins and 
nucleotide de-novo synthesis proteins, with higher expression in cells adapted to serum-
free medium (Baik, et al. 2011). A study that used DNA microarray to study the serum-
free medium adaptation of the human lymphoma cell line, observed higher gene 
expression for cell division and central metabolism genes, and lower gene expression in 
apoptosis genes (Zander and Bemark 2008). Interestingly, in the human lymphoma study, 
genes related to signal transduction and cell adhesion were returned to pre-adaptation 
levels once transferred to a serum containing medium, indicating these genes were 
directly influenced by serum. In a different study using human embryonic kidney (HEK) 
cells, DNA microarrays identified early growth response1 (EGR1) and growth arrest 
specific 6 (GAS6) to have higher expression in serum-free medium adapted cells (Jaluria, 
et al. 2008). Jaluria et al. (2006) subsequently overexpressed EGR1 and GAS6 genes in 
non-adapted HEK cells and observed improvements in growth rates and cell viabilities 
during the serum-free medium adaptation process (Jaluria, et al. 2008). 
 
2.3.2 Temperature studies 
Temperature is one of the most critical and carefully monitored environmental 
factors in mammalian cell culture. CHO cells are typically cultured at a temperature of 
37°C, to mimic the Chinese hamster physiological temperature (Yoon, et al. 2003a). 
However, low temperature cultivation has been widely used as a strategy to improve 
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critical mammalian cell culture performance parameters such as cell viability, protein 
productivity and product quality (Moore, et al. 1997; Kaufmann, et al. 1999; Yoon, et al. 
2003b; Kou, et al. 2011; Fogolı́n, et al. 2004; Fox, et al. 2004). Beneficial effects of low 
culture temperature for CHO cells have been observed around 33°C, where temperatures 
below 33°C have been observed to have detrimental effects on cell growth. For example, 
when CHO cells producing erythropoietin (EPO) were cultured at 30°C, improvements in 
protein productivity were negated by poor cell growth (Yoon, et al. 2003a; Yoon, et al. 
2005; Yoon, et al. 2006a). Low temperature cultivation of CHO cells has been utilized to 
delay the onset of apoptosis in order to extend the production period (Al‐Fageeh, et al. 
2006; Fogolı́n, et al. 2004; Kaufmann, et al. 1999; Moore, et al. 1997; Trummer, et al. 
2006; Yoon, et al. 2006b). Moore et al. (1997) observed that temperature shift from 37°C 
to 30°C in CHO cells resulted in a four-day delay in the onset of apoptosis, possibly due 
to cell growth arrest observed in up to 87% of the cells (Moore, et al. 1997). Additionally, 
CHO cells cultivated under low temperatures experience lower glucose consumption and 
lactate production rate, lower ATP consumption, and higher shear resistance (Al‐
Fageeh, et al. 2006; Masterton and Smales 2014) 
The impact of low temperature cultivation on CHO cell protein productivity, 
however, is not consistent across all cell lines. Low temperature cultivation of several 
CHO cells expressing EPO, C-terminal α-amidating enzyme and tissue plasminogen 
activator (tPA), have resulted in increased specific protein productivity (Furukawa and 
Ohsuye 1998; Kaufmann, et al. 1999; Yoon, et al. 2003b). Several studies have linked the 
improvements in protein productivity towards stability increase in recombinant mRNA 
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and its improved stability at low temperatures (Fox, et al. 2004; Masterton and Smales 
2014; Yoon, et al. 2003a). Despite the decrease in global protein translation, the 
increased mRNA levels are suggested to compensate for it, leading to the occurrence of 
enhanced protein synthesis. Additionally, the decrease in global translation may result in 
‘less competition’ of the recombinant mRNAs with the endogenous mRNAs for cellular 
translational machinery in the ribosome. In contrast, decreased or no change in specific 
protein productivity have been observed during low temperature cultivation of 
recombinant CHO cells and other mammalian cell lines (Barnabé and Butler 1994; 
Sureshkumar and Mutharasan 1991; Yoon, et al. 2003a). The variability of low 
temperature effect on specific protein productivity was also observed between two 
different recombinant proteins produced by same host cell lines and driven by same 
promoters (Yoon, et al. 2003a; Yoon, et al. 2003b). Additionally, the cell-specific impact 
of low temperature was documented when 12 parental clones and their corresponding 
amplified clones did not exhibit similar patterns in protein productivity improvements 
(Yoon, et al. 2006a). These literature studies suggest that the effect of low temperature on 
protein productivity improvements is highly cell line and product specific. The 
differences in protein productivities may arise due to differences in metabolite utilization, 
cell growth and recombinant mRNA expression levels (Marchant, et al. 2008; Masterton 
and Smales 2014).  
Nishiyama et al. (1997) reported the evidence of molecular changes in 
mammalian cells cultured under low temperatures through the discovery of cold 
inducible RNA-binding protein (CIRP) in mouse fibroblast cells. Expression of CIRP at 
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low temperature is related to growth suppression and cell growth arrest (AlFageeh, et 
al. 2006; Masterton and Smales 2014). A genome wide expression analysis of low 
temperature effect on mouse myeloma cells revealed deregulation of genes involved in 
several signaling and metabolic pathways including apoptosis, death receptor, glycolysis, 
and pentose phosphate pathway. Kantardjieff et al. (2010) utilized a proprietary DNA 
microarray to understand improved productivity under low temperature and butyrate 
treatment (Kantardjieff, et al. 2009). Cell cycle and growth factor related genes were 
down regulated while extracellular matrix and fatty acid metabolism genes were up 
regulated. Unfortunately, the use of proprietary DNA microarray in this study makes it 
difficult to confirm these findings. A comprehensive transcriptome analysis will be 
crucial in understanding how the cellular mechanisms are coordinated upon the impact of 
low temperature and why recombinant protein productivity is selectively enhanced in 
some but not all CHO cells. The improved understanding can be utilized to engineer 
CHO cells lines with characteristics of higher productivity and viability usually observed 
at low temperatures, while cultivating CHO cells at 37°C, the optimal growth 
temperature. 
 
2.3.3 pH studies 
Similar to temperature, pH is a critical environmental factor that affects 
mammalian cell cultures. Traditionally, optimum growth pH for mammalian cell culture 
varies between 7.10-7.40  (Borys, et al. 1993; Borys, et al. 1994; Yoon, et al. 2005). In 
CHO cells, variation in pH significantly influences several aspects of cell culture 
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including cell growth, metabolism and recombinant protein production (Borys, et al. 
1993; Kantardjieff, et al. 2011; Miller, et al. 1988; Trummer, et al. 2006; Yoon, et al. 
2005). Specifically, low culture pH (<7.0) can result in improved cell viability, prolonged 
cultivation time and enhanced recombinant protein yield (Miller, et al. 1988; Trummer, et 
al. 2006; Trummer, et al. 2006; Yoon, et al. 2005). For example, Trummer et al (2006) 
observed the highest concentration of fusion protein EPO-Fc due to prolongation of CHO 
cell culture at pH 6.80. Cell metabolism is also significantly affected by culture pH. Yoon 
et al. (2005) observed decreased consumption of glucose and corresponding decrease in 
production of lactate at low pH. The reduction in glucose metabolism caused decrease in 
cell growth rates (Miller, et al. 1988; Trummer, et al. 2006; Yoon, et al. 2005). Based on 
these observations of reduced glucose consumption and lactate production at the pH 
range of 6.80 to 7.10 in multiple antibody producing cell lines, an acidic feed for a large-
scale CHO culture was utilized to reduce lactate production by 60% (Kantardjieff, et al. 
2011). Often times, the growth optimal pH is not necessarily the optimal pH for increased 
protein production. In mouse hybridoma cell line producing antibody, it was observed 
that specific antibody production rate were three times higher at pH 6.80 compared to the 
pH of 7.10-7.40 where pH 7.10-7.40 is ideal for growth (Miller, et al. 1988). In contrast, 
Borys et al. (1993) observed that the pH for maximum specific recombinant protein 
production to be same as optimum growth pH for two CHO cell lines secreting mouse 
placental lactogen proteins (Borys, et al. 1993). Additionally, variable response in 
specific protein productivity has been observed due to changes in pH in CHO cells 
(Borys, et al. 1993; Miller, et al. 1988; Trummer, et al. 2006). While Trummer et al. 
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(2006) observed no change in specific productivities in CHO cells producing EPO-Fc 
between pH range from 6.80 to 7.60, Borys et al. (1993) reported variations in specific 
productivity of mouse placental lactogen protein between pH 6.10 and 8.70 (Borys, et al. 
1993; Trummer, et al. 2006).  
Variations in pH can also influence glycosylation, an important post-translational 
modification that influences protein efficacy (Borys, et al. 1993; Borys, et al. 1994; 
Hayter, et al. 1993; Yoon, et al. 2006b). At extreme pH (pH < 6.80 and pH > 8.20), 
decreasing levels of glycosylation (reduced efficacy) were observed in mouse placental 
lactogen-I produced by CHO cells grown in T-flask cultures, where pH was not 
controlled (Borys, et al. 1993). Under a pH-controlled environment, glycosylation was 
not affected for any pH in the range of 6.85 to 7.60 (Yoon, et al. 2005). Additionally, 
metabolic waste products such as ammonia have been observed to decrease glycosylation 
levels of a protein in a pH dependent manner (Borys, et al. 1994; Harcum 2005). Despite 
being one of the most basic and critical parameters, currently there are no known 
transcriptome studies in literature understanding the response of CHO cells or other 
mammalian cells to extracellular pH variations. Nevertheless, transcriptome responses to 
pH stresses observed in several bacterial strains indicated gene expression changes 
related to key cellular functions such as metabolism, transport, and oxidative stress (Brat, 
et al. 2009; Kannan, et al. 2008; Leaphart, et al. 2006; Wilks, et al. 2009). These literature 
results suggest that the optimal pH for growth and protein production need to be 
determined for every recombinant cell line due to the lack of clear understanding of the 
cellular mechanisms. To further elucidate the mechanism of pH effect on CHO cell 
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culture, transcriptome understanding of the pH influence on CHO cell culture is 
necessary. 
 
2.3.4 Glucose studies 
For a majority of the mammalian cell lines, glucose serves as the primary carbon 
source required for growth and maintenance. Several important metabolic pathways such 
as glycolysis, pentose pathway and TCA cycle are all involved in the catabolism of 
glucose. Key intermediates for the synthesis of cellular components such as lipids, sugar 
chains and nucleic acids are generated during glycolysis (Ozturk and Hu 2005).  
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Figure 2.3: Simplified A) glycolysis and B) tricarboxylic acid (TCA) cycle 
showing basic glucose metabolism. Abbreviations: AcCOA – Acetyl coenzyme A 
synthetase, AKG – Alpha-ketoglutarate, Cit – Citrate, Fum – Fumarate, Mal – Malate, 
Suc – Succinate, Pyr – Pyruvate, Pyr.m – Pruvate (Mitochondrial).   
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Most mammalian cell culture media, including serum-free media, typically 
contain glucose concentrations between 25 mM to 35 mM (~4.5 g/L to 6.5 g/L). 
However, glucose concentrations above 10 mM glucose are analogous to diabetic levels 
in humans, suggesting that the mammalian cells are cultivated in excess glucose 
(American Diabetes Association 2008). In the presence of excess extracellular glucose 
concentrations, the rate of glycolysis in CHO cells is high, as single cells have no means 
to regulate the uptake of glucose. This results in CHO cells consuming large quantities of 
glucose and subsequent production of metabolic waste like lactate as shown in Figure 2.3 
(Ozturk and Hu 2005). The production of lactate, due to incomplete oxidation of glucose, 
is energy inefficient, producing 2 moles of ATP as opposed to 36 moles of ATP during 
complete oxidation of glucose through glycolysis and TCA cycle (Ozturk and Hu 2005). 
The conversion of pyruvate to lactate is also coupled with the regeneration of NAD+ from 
NADH, where NAD+ is necessary to sustain high glycolytic flux (Mulukutla, et al. 2010; 
Mulukutla, et al. 2012; Seth, et al. 2006). The low energy produced due to incomplete 
glucose oxidation results in higher glucose consumption rates and inevitably leads to 
increased lactate production, which can inhibit CHO cell growth and negatively affect 
protein productivity (Mulukutla, et al. 2010; Ozturk and Hu 2005). Interestingly, 
metabolic flux analysis of recombinant CHO cells in a fed batch culture revealed high 
glycolytic activity, lactate production and low oxidative metabolism was associated with 
maximum growth rates observed during early exponential phase (Templeton, et al. 2013). 
In contrast, the protein production phase was positively correlated with oxidative TCA 
cycle flux. Lactate production in large-scale culture additionally causes osmolarity 
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changes, especially when online pH control via base additions are used to counteract the 
pH decrease cause by lactate (Templeton, et al. 2013). In late stages of fed batch cultures, 
a metabolic shift towards lactate consumption can occur, alleviating the inhibitory effect 
of lactate, improving cell viability and increasing protein titers (Mulukutla, et al. 2012). 
The lactate shift primarily occurs at low glucose levels and high lactate concentrations 
but is also observed during high glucose concentration when lactate concentrations 
become inhibitory to glycolysis (Mulukutla, et al. 2012).  
For over 25 years, several approaches have been attempted to minimize lactate 
buildup in CHO cell cultures but the problem still persists. Cell engineering approaches 
to control lactate production included down-regulation of lactate dehydrogenase (LDH), 
overexpression of pyruvate carboxylase or regulating glucose transporters to reduce 
glucose flux but were unsuccessful (Seth, et al. 2006). For example, limiting LDH 
activity in CHO cells reduced specific lactate production; however the lactate yield from 
glucose remained unchanged (Seth, et al. 2006). Alternatively, maintaining low glucose 
concentrations has been attempted to reduce the glucose intake by cells. In a continuous 
culture of CHO cells, Hayter et al. (1992) observed low concentrations of glucose (2.75 
to 4.25 mM) were associated with decreasing glucose consumption rates and low yields 
of lactate from glucose (Hayter, et al. 1992). In a separate study, low glucose 
concentrations (5 mM) exerted little change on CHO cell intracellular metabolites 
including ATP, amino acids and organic acids involved in TCA cycle (Lu, et al. 2005). 
However, further studies are required to fully understand the complexity of glucose 
metabolism.   
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CHAPTER THREE 
TRANSCRIPTOME-WIDE PROFILING OF CHINESE HAMSTER OVARY (CHO) 
CELL LINES USING RNA-SEQ TO IDENTIFY CRITICAL GENE EXPRESSION 
BOTTLENECKS IN SERUM-FREE MEDIUM ADAPTATION PROCESS 
 
3.1 Abstract 
Chinese hamster ovary (CHO) cell lines are a well-established mammalian cell line used 
for over 25 years, in the biopharmaceutical industry for the production of recombinant 
protein therapeutics. CHO cell lines are the preferred host for protein expression due to 
their ability to perform human-like post-translational modification of the product protein, 
ease of culturing in large-scale bioreactors and protein expression stability. Like most 
mammalian cells, parental CHO cell lines are grown as adherent cells in serum 
supplemented media. Due to regulatory issues about the use of serum, CHO cells are 
grown as suspension cells in serum-free media in large industrial bioreactors. Hence, 
CHO cell lines have to be adapted to serum-free media by gradual reduction of serum in 
media. Adaptation of CHO cells to serum-free media is a tedious, sensitive process and 
can take anywhere between 2-6 months for the cells to be fully adapted. Current literature 
on the serum-free adaptation process is limited and not completely understood. The 
objectives of this study are to elucidate the transcriptional changes during the process of 
serum-free adaptation of CHO cells to gain a better understanding of the adaptation 
process and to identify potential targets for adaptation optimization. Two CHO cell lines 
were gradually adapted to serum-free medium: CHO DP-12 – an IgG producing cell line 
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and CHO DHFR- – the parental cell line. Although CHO DP-12 completely adapted to 
serum-free medium, the CHO DHFR- cells could not successfully proceed beyond 
medium containing less than 5% serum. For transcriptome analysis, RNA was extracted 
from the two cell lines at different stages of serum-free adaptation and sequenced by 
Illumina HiSeq 2500. Transcriptome analysis identified serum sensitive genes in both 
rCHO DP-12 and CHO DHFR-. Additionally, the differences between the two CHO cell 
lines that contributed to the adaptation of CHO DP-12 and hindered the adaptation of 
CHO DHFR- were identified. Additionally, Serum sensitive genes in several functional 
classes such as glycosylation, apoptosis and cell cycle genes were investigated. 
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3.2 Introduction 
 CHO cells are widely used in the biopharmaceutical industry, particularly in the 
manufacture of recombinant protein therapeutics including antibodies, interferons, blood 
factors and growth factors (Butler and Meneses-Acosta 2012; Datta, et al. 2013; 
Kantardjieff and Zhou 2013; Omasa, et al. 2010). It is estimated that over 35% of the 
biopharmaceuticals commercially available are manufactured using CHO cells, 
accounting for more than $100 billion in global revenues (Bandaranayake and Almo 
2013; Jayapal, et al. 2007; Kantardjieff and Zhou 2013). Even though there are several 
mammalian cell line options, the popularity of CHO cells is due to several advantages 
offered by it including easy scale up to large-scale processes, well-developed transfection 
systems for easy recombinant protein expression and the ability to perform human-
compatible protein post-translational modifications (Kim, et al. 2012; Omasa, et al. 2010; 
Wuest, et al. 2012). 
 The culture media used at small scale for most mammalian cells, including CHO 
cells, require the addition of 10% serum, mainly fetal bovine serum (FBS), to support cell 
growth (Gstraunthaler 2003; Ozturk and Hu 2005; Shah 1999). The use of serum, 
however, is associated with several disadvantages, such as not being completely defined, 
batch-to-batch variability, serum protein interference in purification process, and most 
importantly, serum is a potential source of contaminants, such as bacteria, viruses, 
mycoplasma, and prions (Freshney 2005; Ozturk and Hu 2005; Schröder, et al. 2004; 
Wessman and Levings 1999). For the aforementioned reasons, the use of serum in the 
biopharmaceutical production processes complicates regulatory approval and can 
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compromise process robustness (Even, et al. 2006). Hence, CHO cells are preferred to be 
cultured in serum-free medium for commercial production processes. In order to 
transition from a small-scale laboratory process to a large-scale commercial process, 
CHO cells are often adapted to serum-free medium; but the adaptation process is tedious 
and can take anywhere between 2-6 months (Astley and Al-Rubeai 2008; Baik, et al. 
2011; Rasmussen, et al. 1998; Rodrigues, et al. 2013; Sinacore, et al. 1996). The 
reduction of nutrient-rich serum from the medium during the adaptation process for CHO 
cells often results in growth declination, disturbances in cell cycle progression, activation 
of apoptosis pathways and cell death (Rodrigues, et al. 2013; Zhu, et al. 2006). 
Additionally, serum removal has also been reported to impact protein productivity and 
protein glycosylation quality (Costa, et al. 2013; Gawlitzek, et al. 1995; LeFloch, et al. 
2006; Watson, et al. 1994). To minimize the effects of serum withdrawal, CHO cells are 
normally adapted to serum-free medium by gradually lowering serum concentrations in a 
step-wise manner over several weeks. Sinacore et al. (2000) described a three-step 
protocol to adapt mammalian cells, particularly CHO cells, to serum-free and high-
density suspension cultures (Sinacore, et al. 2000); however the adaptation process is 
highly dependent on the cell type (Rodrigues, et al. 2013). 
Adaptation of CHO cells to serum-free medium has these long timelines and 
negative attributes partly due to an inadequate understanding of serum-free medium 
adaptation of CHO cells at cellular and molecular level. Currently, only limited studies 
have examined the serum-free adaptation process of mammalian cell lines using ‘omics-
based techniques (Baik, et al. 2011; Jaluria, et al. 2008; Zander and Bemark 2008). These 
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studies have identified changes at transcriptome and proteome level occurring in serum-
free adapted cells using techniques such as DNA microarrays and 2-Dimensional SDS-
PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis). However, a global 
understanding of the serum-free medium adaptation process is still lacking. The advent of 
RNA-Seq, which utilizes high-throughput deep sequencing technology, enables the 
profiling of the whole transcriptome and offers several advantages over DNA microarray 
techniques, including wider detection range, avoids cross-hybridization, high 
reproducibility and consistency (Fu, et al. 2009; Marioni, et al. 2008; Mortazavi, et al. 
2008). The recent establishment of parental CHO-K1 and Chinese hamster reference 
genome has opened up new avenues for understanding CHO cells, which was not 
previously possible (Lewis, et al. 2013; Xu, et al. 2011). 
 In this study, high-throughput next-generation transcriptomic technology, RNA-
Seq, was utilized to characterize and understand the serum-free medium adaptation 
process. RNA samples were extracted from two CHO cell lines – a recombinant CHO 
DP-12 cell line and a non-recombinant parental CHO DHFR- cell line, at different 
adaptation stages to monitor the changes occurring in the transcriptome. The objective of 
the investigation was to identify critical genes and gene families required for successful 
serum-free adaptation by characterizing the transcriptional differences during the serum-
free medium adaptation process for CHO cells. The impact of serum-free medium 
adaptation process on protein glycosylation, cell cycle and apoptosis gene expression was 
additionally evaluated. Gene expression differences between the successfully adapted 
recombinant CHO cell line and the unsuccessful non-recombinant CHO cell line were 
31 
 
also identified to gain insights into genes that may support/hinder successful serum-free 
medium adaptation process. 
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3.3 Materials and Methods 
3.3.1 CHO Cell Lines, Medium, Culture Conditions, and Quantification 
 All CHO cell lines were obtained from the American Type Culture Collection 
(ATCC). The recombinant cell line rCHO DP-12 (ATCC® CRL-12445™) produces a 
human monoclonal antibody (IgG1) against Interluekin-8 (IL-8). CHO DHFR- (ATCC® 
CRL-9096™) is a non-recombinant cell line and the parental cell line of CHO DP-12. 
Both CHO cell lines were originally cultured in Dulbecco’s Modified Eagle medium 
(DMEM) (Life Technologies, NY, USA), which contained 4.5 g/L glucose and 10% v/v 
FBS (Life Technologies, NY, USA) supplemented with 5mM L-glutamine (Life 
technologies, NY, USA) and 10 µg/mL ciprofloxacin-HCl (Mediatech Inc., VA, USA). 
Additionally, CD CHO medium (Life technologies, NY, USA), a chemically defined 
protein-free and serum-free medium, containing 6 g/L glucose and supplemented with 5 
mM L-glutamine (Life Technologies, NY, USA) and 10 µg/mL ciprofloxacin-HCl 
(Mediatech Inc., VA, USA) was for the serum-free medium adaptation experiments. 
Cells were grown in 25 cm2 flasks (Corning Inc, NY, USA) in an incubator maintained at 
37°C and humidified 5% CO2 atmosphere. Suspension cultures were shaken at 120 rpm. 
Anti-clumping agent (Life technologies, NY, USA) was added (1:250) to the CD CHO 
medium.  Cell concentrations were measured using a Scepter 2.0 Handheld Automated 
Cell Counter (Millipore, MA, USA). Glucose and lactate measurements were performed 
using Yellow Springs Instruments (YSI) 2900 Biochemistry Analyzer (Yellow Springs, 
OH, USA). Statistical analysis to find differences in growth rates was performed using 
JMP software (SAS institute, NC, USA).  
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3.3.2 Adaptation to Serum-Free Medium 
For the prescriptive serum-free medium adaptation process, both CHO cell lines 
were gradually shifted to lower serum concentrations by increasing the proportion of CD 
CHO medium relative to the DMEM with 10% FBS. For example, three parts DMEM 
with 10% FBS mixed with one part CD CHO contains 7.5% serum. Cells were seeded at 
a concentration of 2 x 105 cells/mL in medium with the next lower serum concentration. 
The cells were considered to be adapted to a serum concentration when all three criteria 
met for at least three passages: 1) high cell viabilities were reached (greater than 90% 
viability), 2) high cell concentrations were reached (greater than 1.5 x106 cells/mL), and 
3) normal cell doubling times were observed (less than 24 hours). Once the cells were 
adapted to a particular serum concentration, stock cultures were prepared and frozen. The 
cells were migrated to a medium with a lower serum concentration and the process was 
repeated until the cells had adapted to a serum-free medium or the cells would not adapt 
to a lower serum concentration.  
  
3.3.3 RNA Isolation 
For transcriptome analysis of the serum-free adaptation process, CHO cell 
samples at different stages of adaptation were collected for the two CHO cell lines (rCHO 
DP-12 and CHO DHFR-), in biological duplicates. Total RNA samples were collected 
from the mid-exponential growth phase, where RNAprotect® cell reagent (QIAGEN, 
Hilden, Germany) was added to the cell broth to stabilize the RNA. The total RNA was 
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extracted, by using RNeasy plus mini kit, into a 1.5 mL RNAase-Free, DNAase-Free tube 
and stored in -80°C (QIAGEN, Hilden, Germany). NanoDrop 8000 UV-Vis 
spectrophotometer (Thermo Scientific, MA, USA) and Agilent 2100 Bioanalyzer System 
(Agilent Technologies, CA, USA) were used to confirm the quality of the RNA samples.    
 
3.3.4 Library Synthesis, Sequencing and Reference Mapping 
The cDNA libraries for whole transcriptome sequencing were constructed by 
following the recommended protocol of the TruSeq RNA sample preparation v2.0 kit 
(Illumina, San Diego, CA). Briefly, messenger RNA (mRNA) was enriched from total 
RNA using poly-T magnetic beads. The mRNA was cleaved into fragments by a non-
specific RNA endonuclease and the fragmentation products were synthesized into 
complementary DNA (cDNA) using reverse transcriptase and DNA polymerase enzymes, 
respectively. The cDNA products were end repaired to flush, A-tail, and phosphorylate 
the DNA ends. These products were then ligated to adapters that serve as priming sites 
for enrichment by PCR to create the cDNA libraries for sequencing. Each library 
contained an individual specific DNA index used for multiplexing during massively 
parallel sequencing. The cDNA libraries were quality validated on an Agilent 2100 
Bioanalyzer System to ensure proper fragment distribution (~260 bp) and removal of 
adapter dimers. Sequence libraries were multiplexed and sequence data collected on two 
lanes of a HiSeq 2500 (Illumina, San Diego, CA) at the Genomics division of David H. 
Murdock Research Institute (Kannapolis, NC) using a 2 × 101 bp, paired end read type. 
Raw sequence reads were de-multiplexed on the instrument and reads greater than or 
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equal to 36 bp were cleaned of adapter and low quality bases (less than Phred 15) with 
the Trimmomatic software package (Bolger, et al. 2014). 
The trimmed reads obtained were mapped on to the Chinese hamster reference 
genome sequence (RefSeq AMDS00000000, AMDS01000000) with the Subread Aligner 
(v1.4.5) (Liao, et al. 2013b). Subread performed local alignment of the reads and reported 
the locations with the largest overlap among the reads. FeatureCounts was used to assign 
the reads to the target genes and summarized the data into a read counts table (Liao, et al. 
2013a). The read counts tables were subsequently used as input for the differential gene 
expression analysis.  
 
3.3.5 Differential Gene Expression Analysis and Gene Ontology Analysis 
Differential gene expression analysis of the RNA-seq data used the edgeR 
software package for data filtering and statistical analysis (Robinson, et al. 2010). The 
software edgeR utilizes a negative binomial distribution model to capture the quadratic 
mean-variance relationship common to RNA-Seq data (Chen, et al. 2014; Robinson and 
Smyth 2008). Additionally, edgeR employs an empirical Bayes method to stabilize over-
dispersion across genes by sharing information across all observations including 
replicates (McCarthy, et al. 2012; Robinson and Smyth 2007; Robinson, et al. 2010). The 
steps used for RNA-Seq statistical analysis were a) filtering low expressed genes, b) 
normalizing the library, c) plotting the multidimensional scaling graph, d) identifying 
differentially expressed genes using generalized linear model and e) analyzing genes for 
overrepresentation by gene ontology (GO) enrichment analysis using GOseq. The 
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filtering criteria used to remove genes with low expression was that a gene needed to 
have greater than 10 count-per-million (CPM) in at least two samples (Appendix A.1) 
(Anders, et al. 2013). The 10 count-per-million was selected based on the point of 
influxion from the plot of normalized expression level arranged in ascending order of 
expression. The library sizes for all samples were normalized using trimmed mean of M-
values (TMM) method in edgeR (Robinson and Oshlack 2010). The multidimensional 
scaling (MDS) plot was used to visualize the similarities and dissimilarities between the 
replicates and samples (Appendix B.1). Additionally, an estimation of tagwise dispersion 
related to the design matrix was conducted using the quantile-adjusted conditional 
maximum likelihood (qCML) method (McCarthy, et al. 2012). To identify the 
differentially expressed genes, a one-way unbalanced layout with each condition as 
individual group was used for all pairwise comparisons. A Benjamini-Hochberg 
procedure was used to control for false discovery rates (FDR) and FDR ≤ 0.01 was used, 
unless otherwise specified (Benjamini and Hochberg 1995). The differentially expressed 
genes were used for gene ontology enrichment analysis using the goseq software – a R 
based Bioconductor package (Young, et al. 2012). GOseq accounts for selection bias for 
long and overexpressed gene sequences by calculating the Probability Weighting 
Function (PWF) (Oshlack and Wakefield 2009). For GO analysis, goseq uses two vectors 
– one containing all the measured genes and the other containing the differentially 
expressed genes. Additional information containing genes length and the GO categories 
associated with the genes were supplied. GO terms with p ≤ 0.05 from the over-
representation test were considered to be statistically significant. Additionally, manual 
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screening of gene and gene families, that had common stem in its gene symbol, with 
greater than 1.5-fold expression change was performed to identify genes sensitive to 
serum-free medium adaptation process. 
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3.4 Results and Discussion 
Previously, several reports have described the adaptation to serum-free medium 
for CHO cells and a few other mammalian cell lines (Lang, et al. 1991; Ozturk, et al. 
2003; Sinacore, et al. 2000). All of these methods share a common attribute, in that; the 
procedures are long, tedious and labor-intensive. Figure 2.2 compares the timelines of 
serum-free medium adaptation for CHO cell lines. From the timeline, it can be clearly 
seen that the recombinant CHO cell lines, rGS-CHO and rCHO, on average adapted 
much quicker to serum-free medium than the non-recombinant CHO cell lines CHO-K1, 
CHO DUKX and CHO DUXB11. Our earlier work to adapt the rCHO DP-12 and CHO 
DHFR- cell lines to a common serum-free medium using an ad-hoc adaptation process, 
also observed that the recombinant cell line adapted more quickly (data not shown).  
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3.4.1 Prescriptive serum-free medium adaptation process for rCHO DP-12 and 
CHO DHFR- 
In this study, rCHO DP-12 and CHO DHFR- were adapted to serum-free medium 
by gradually reducing the serum concentration by increasing the proportion of CD CHO 
medium and decreasing the portion of DMEM medium in the culture media. The CHO 
cells were considered to be adapted to a particular serum concentration when all three 
criteria were reached for at least three passages: 1) high cell viabilities (greater than 90% 
viability), 2) high cell concentrations (greater than 1.5 x 106 cells/mL), and 3) normal cell 
doubling times (less than 24 hours).  Once the cell line was adapted, the CHO cells were 
migrated to a medium with a lower serum concentration. 
The serum-free medium adaptation timelines for rCHO DP-12 and CHO DHFR- 
are shown in Figure 3.2. The rCHO DP-12 cells were successfully adapted to serum-free 
medium (0% serum) within 65 days. In contrast, the non-recombinant parental CHO 
DHFR- cell line was only successfully adapted to 5% serum at 65 days, and failed to 
adapt to serum-free medium, even after 120 days. Adaptation of the CHO DHFR- cells to 
any serum concentration below 5% was not successful, even when 4% serum was 
attempted, instead of the normal decrease to 2.5% serum. The adaptation timelines for the 
rCHO DP-12 and CHO DHFR- cell lines observed in this study are consistent with the 
adaptation timelines observed in the literature (Figure 2.2).  The apparent increased 
robustness of the recombinant CHO cell lines might be attributed to the various selection 
and amplification steps used to generate these recombinant cell lines, i.e., using toxic 
chemicals such as dimethyl methotrexate(Mariani and Schimke 1984).  
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Figure 3.1: Serum-free medium adaptation timelines of the two CHO cell lines, rCHO 
DP-12 and CHO DHFR-, used in this study. The downward black arrows indicate the 
different adaptation steps during which RNA samples were harvested. The dashed arrow 
at the end of CHO DHFR- timeline indicates the unsuccessful adaptation attempts beyond 
5% serum. 
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In order to characterize the CHO cell transcriptional landscape at different points 
in the serum-free medium adaptation process, RNA-samples were isolated from both 
CHO cell lines cultured in the different serum concentrations – 10%, 5% and 0% serum 
for rCHO DP-12 and 10% and 5% serum for CHO DHFR-. The growth profiles for these 
five culture conditions are shown in Figures 3.2A and 3.2B. Figure 3.2A shows the 
growth profiles of the cultures in 10% serum, which are anchorage-dependent, while 
Figure 3.2B shows the growth profiles of the cultures in 5% and 0% serum, which were 
in suspension. The growth rates for rCHO DP-12 and CHO DHFR- cells at 10% serum 
were the same at 0.026 h-1. The growth rates observed for the CHO cells in 5% serum 
were not significantly different for the two cell lines, at 0.035 h-1 (p < 0.05), after 
omitting the first time point at zero hours for CHO DHFR- due to lag in growth during 
the first 24 hours of culture. The growth rate of rCHO DP-12 cells in the 0% serum, CD 
CHO medium, was 0.036 h-1, which was not significantly different from the 5% serum 
rCHO DP-12 culture growth rates (p < 0.05).  
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Figure 3.2: Growth profiles of rCHO DP-12 and CHO DHFR- grown at different serum 
concentrations during the adaptation process. CHO DP-12 (open) and CHO DHFR- 
(closed) cultivated at A) 10% serum media (squares) and B) 5% serum media (circles) 
and 0% serum media (diamonds) is shown. The black arrows indicate the RNA extraction 
from the mid exponential growth phase.   
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The RNA samples were taken from the mid-exponential phase for each culture in 
duplicates between 44-48 hours as indicated by black arrows in Figure 3.2A and 3.2B. At 
the time of RNA harvest, glucose concentration was not limiting (> 15 mM) and the 
lactate concentrations were not inhibitory (< 25 mM) (Appendix 3.3B). RNA-Seq data 
obtained from HiSeq 2500 was mapped to the Chinese hamster reference genome (Lewis, 
et al. 2013). The raw data mapped to a total of 27,629 genes. As mentioned in the 
Materials and Methods, the low count genes were filtered (CPM ≥ 10 in at least two 
samples) and the number of genes was reduced to 10,774 genes, which were used for 
differential gene expression analysis using a one-way layout. The number of 
differentially expressed genes in each of the pairwise comparison is shown in Table 1. 
Four of these comparisons represent the main effect of serum as indicated in bold text. 
And two comparisons represent the main effect of cell line as indicated in italics. To 
identify genes most sensitive to serum, three of the four serum pairwise comparison gene 
groups were analyzed using a Venn diagram. The comparison of rCHO DP-12 in 0% 
serum to 10% serum was not used. Figure 3.3A and 3.3B shows the Venn diagram of 
these three pairwise comparisons, segregated by genes that had higher and lower 
expression between the pairs, respectively (FDR ≤ 0.01). Three of the intersections from 
Venn diagram represent genes that provide insight into the serum-free adaptation process. 
The first intersection is the intersection of all three groups and has 185 higher expression 
genes and 282 lower expression genes (Figure 3.3A, 3.3B). This intersection represents 
the genes that were serum sensitive in both CHO cells - rCHO DP-12 and CHO DHFR-, 
and was also sensitive throughout the adaptation process in rCHO DP-12. The second 
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intersection, which is only between the rCHO DP-12 groups, has 251 higher expression 
genes and 350 lower expression genes (Figure 3.3A, 3.3B). This intersection represents 
the genes that had continued to be serum-sensitive in rCHO DP-12 throughout the 
adaptation process. The third intersection represents the genes that had common 
responses in both cell lines during the adaptation from 10% serum to 5% serum. This 
group has 766 higher expression genes and 572 lower expression genes. These genes 
represent gene expression changes necessary for adaptation to 5% serum medium. These 
groups were used for functional analysis of groups such as glycosylation, apoptosis and 
cell cycle, and gene ontology (GO) enrichment analysis.  
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Table 3.1: Pairwise comparisons of rCHO DP-12 and CHO DHFR- between the cell lines 
and different serum concentrations (FDR ≤ 0.01). Numbers in parenthesis indicate the 
number of genes with greater than 1.5-fold difference in expression. The numbers in bold 
represent comparisons where the serum adaptation was the main effect. The numbers in 
italics represent comparisons where the cell line was the main effect. 
Cell 
Lines 
rCHO DP-12 CHO DHFR- 
Serum 10% 5% 0% 10% 5% 
rCHO  
DP-12 
10%   
4363 
(1712) 
6066 
(3006) 
4229 
(1803) 
6159 
(2034) 
5%   
4667 
(1790) 
5149 
(2300) 
5467 
(2298) 
0%   
6166 
(3187) 
6479 
(3319) 
CHO 
DHFR- 10%   
4045 
(1461) 
5%           
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Figure 3.3: Venn diagram of three pairwise comparisons – DP12 5%/10%, DP12 0%/5% 
and DHFR 5%/10%, with serum as the main effect to identify common serum sensitive 
genes. Differentially expressed genes in these comparisons were separated into A) Higher 
expression and B) Lower expression to identify the genes most sensitive to serum (FDR ≤ 
0.01).  
47 
 
3.4.2 Influence of the serum-free medium adaptation process on glycosylation gene 
expression 
CHO cells are widely used in biopharmaceutical industry to produce recombinant 
glycosylated proteins with therapeutics/diagnostic uses (Jayapal, et al. 2007; Kantardjieff 
and Zhou 2013). One of the major advantages of using CHO cells is its ability to perform 
human-like post-translational modifications. Glycosylation, a post-translational 
modification, is a critical product quality attribute that dictates efficacy, immunogenicity 
and stability of the therapeutic protein (Walsh and Jefferis 2006). Consistent protein 
glycosylation is required to obtain regulatory approval (Hossler, et al. 2009). Several 
studies have documented the impact of serum-free medium adaptation on the 
glycosylation patterns of the recombinant proteins; however no study has investigated the 
impact of the adaptation process on glycosylation gene expression (Costa, et al. 2013; 
Gawlitzek, et al. 1995; LeFloch, et al. 2006). To assess the impact of the serum-free 
medium adaptation process on CHO cell protein glycosylation, the gene expression levels 
for 264 glycosylation-related genes were compared with the three interaction lists – 1) 
genes that were serum sensitive in both CHO cells, 2) genes that were serum sensitive in 
rCHO DP-12 only and 3) genes that were sensitive to transition from 10% to 5% serum in 
both CHO cells. Overall, 38 glycosylation related genes were impacted by serum-free 
medium (Table 2). Of the 38 genes, there were 11 genes that were of importance from the 
biopharmaceutical standpoint and they can be broadly categorized into four groups: 
sialidase (Neu2), sialyltransferases (ST3gal2, ST3Gal3, ST3Gal4, ST3Gal5), 
fucosyltrasnferase (Fut8, Pofut2) and mannosidase (Man1a2, Man2b1).   
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Table 3.2 - Glycosylation-related genes sensitive to serum-free medium adaptation 
process (FDR ≤ 0.01) 
    Fold Change 
Gene 
Symbols Gene Family 
DP12 
0/5 
DP12 
5/10 
DHFR 
5/10 
Genes sensitive to serum in both CHO cells 
Chst11 Sulfotransferases -4.9 -1.5 -1.4 
Cmas Nucleotide Synthesis  -1.5 -3.0 -1.4 
Extl2 GlcNAc-transferases -1.7 -1.7 -1.9 
Fut8 Fucosyltransferases -2.1 -1.4 -1.4 
Galnt1 GalNAc-transferases -1.4 -4.3 -1.2 
Hk1 Nucleotide Synthesis  -1.2 -1.4 -1.4 
Lfng GlcNAc-transferases -1.4 -1.9 -2.6 
Man1a2 Mannosidase -1.9 -1.4 -1.2 
Neu2 Sialidases -30.9 -9.9 -3.3 
Slc35a3 Nuc. Sugars Transporters -1.8 -1.5 -1.5 
St3gal3 Sialyltransferases 1.6 1.5 1.7 
St6galnac6 Sialyltransferases 1.9 1.2 1.7 
Ugp2 Nucleotide Synthesis  1.7 1.3 1.7 
 
Genes sensitive to serum in rCHO DP-12 only 
Alg6 Glucosyltransferases 1.2 1.8 
Extl1 GlcNAc-transferases -2.8 -2.3 2.6 
Galnt7 GalNAc-transferases 2.1 1.2 
Gba Lysosomal Enzymes -1.4 -1.2 
Gmppa Nucleotide Synthesis  -1.6 -1.2 1.4 
Gpi Nucleotide Synthesis  1.3 1.3 
Hpse Heparanases -2.6 -1.6 
Hs6st1 Sulfotransferases -1.7 -2.8 
Pofut2 Fucosyltransferases -1.4 -1.3 
St3gal4 Sialyltransferases 1.5 1.3 
St3gal5 Sialyltransferases -1.4 -1.3 1.4 
 
Genes sensitive to transition from 10% to 5% serum in both CHO cells 
Alg8 Glucosyltransferases 1.4 1.3 
Alg9 Mannosyltransferases 1.7 -1.3 -1.2 
B4galt2 Galactosyltransferases 1.4 1.8 
Extl3 GlcNAc-transferases -1.6 1.4 1.5 
Fuca1 Fucosidases -2.5 -1.3 
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Table 3.2 - Glycosylation-related genes sensitive to serum-free medium 
adaptation process (FDR ≤ 0.01) 
Galnt11 GalNAc-transferases 1.4 1.5 
Glce Miscellaneous -1.4 -1.4 
Gnpda1 Nucleotide Synthesis  1.7 1.7 
Gusb Galactosidase -1.4 1.4 1.4 
Lipa Lysosomal Enzymes 1.3 1.3 
Man2b1 Mannosidase 1.5 1.9 
Pomgnt1 GlcNAc-transferases 1.6 1.5 
St3gal2 Sialyltransferases -1.6 -1.2 
Sulf2 Sulfatases 1.5 -4.6 -1.7 
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The sialidase gene, Neu2, experienced the highest fold-change during the serum-
free medium adaptation process (Figure 3.4A). Neu2 had over 300-fold decrease in 
expression throughout the serum-free medium adaptation. Sialidases are a class of 
glycosidic enzymes that cleave the terminal monosaccharides, particularly sialic acids, 
from the glycoprotein (Miyagi and Yamaguchi 2012). The decrease in Neu2 gene 
expression could directly impact the activity of sialidases, thereby affecting sialylation of 
glycoproteins. The presence of sialic acid residues can change the physiological role of 
IgGs from pro-inflammatory molecule to anti-inflammatory agent (Bork, et al. 2009; 
Costa, et al. 2013; Hossler, et al. 2009). The decrease in Neu2 expression is consistent 
with higher sialic acid content observed for a IgG1 in serum-free medium and the 
decrease in sialylation of interferon-γ due to the presence of serum observed previously 
in the literature (LeFloch, et al. 2006).  
Two mannosidases, Man1a2 and Man2b1, were observed to be serum sensitive 
but change in expression due to the adaptation process was different for both genes 
(Figure 3.4B). Man1a2 had a significant decrease in expression during the adaptation 
process in both CHO cells, while Man2b1 had a significant increase in expression in both 
CHO cells while transitioning from 10% to 5%. Mannosidases are involved in trimming 
the mannose residues from the product protein before performing glycan structure 
modification. The presence of high mannose structures in the glycoprotein has been 
associated with reduced efficacy of the recombinant proteins(Costa, et al. 2013). The 
expression of other members of the mannosidases family remained unchanged for most 
part of the adaptation process. 
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The sialyltransferase genes were significantly impacted by serum-free medium 
adaptation process (Figure 3.4C). ST3Gal3 and ST3Gal4 had an overall increase in 
expression during the adaptation process, while ST3Gal2 decrease in its expression 
during serum-free medium adaptation. It was interesting to note that while the expression 
of ST3Gal5 during the adaptation process decreased in rCHO DP-12, it had an increase in 
expression in CHO DHFR-. Sialidase and sialyltranferase gene expression could directly 
impact the sialylation of the recombinant protein. The presence of terminal sialic acids 
can improve the activity, stability of the glycoprotein and can promote anti-inflammatory 
response (Bork, et al. 2009; Hossler, et al. 2009). The overall increase in sialyltransferase 
gene expression during adaptation process, in addition to the decrease in Neu2 
expression, could improve the sialylation of the protein. Indeed, as noted earlier, studies 
have reported increase in sialylation under serum-free medium conditions (LeFloch, et al. 
2006; Patel, et al. 1992). 
Fut8, which is a major fucosyltransferase gene, had a decrease in expression 
during adaptation process in both CHO cells (Figure 3.4D). Additionally, Pofut2, another 
fucosyltrasnferase gene, decreased in expression in rCHO DP-12 but it remained 
unchanged in CHO DHFR- during the adaptation process. The decrease in expression of 
fucosyltransferases could potentially lead to the production of recombinant proteins with 
decreased/no fucose residue. The lack of core fucose in antibodies has been observed 
with enhanced efficacy through antibody-dependent cell-mediated cytotoxicity (ADCC). 
Indeed, Costa et al. (2013) observed lowest level of core fucose concentration at 0.625% 
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serum concentration while profiling glycans concentration during the serum-free medium 
adaptation (Costa, et al. 2013).  
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Figure 3.4: Glycosylation genes significantly impacted by the serum-free medium 
adaptation process in rCHO DP-12 and CHO DHFR- (FDR ≤ 0.01). Specifically, the gene 
families affected were A) Sialidase, B) Mannosidase, C) Sialiyltransferases and D) 
Fucosyltransferases. 
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3.4.3 Cell shock related genes 
Serum-free medium adaptation process in CHO cells and other mammalian cell 
lines often results in cell shock, subsequently leading to growth arrest and cell death. The 
shock experienced by cells during the adaptation process is mainly due to the removal of 
several nutrients present in serum, such as growth factors, vitamins, and amino acids 
(Sinacore, et al. 2000). Thus, the expression of genes related to cell cycle progression and 
apoptosis genes were examined at different stages of the serum-free medium adaptation 
process. 
 
3.4.3.1 Cell cycle related genes  
Cell cycle genes that belonged to various cell cycle phases such as G-phase, M-
phase, S-phase and DNA replication genes, as well as regulation related genes such as 
cell cycle checkpoint, cell cycle arrest and progression of cell cycle were examined. In 
this study, the serum sensitive genes were compared to 84 cell cycle related genes that 
were compiled by SABiosciences (Fischer, et al. 2011; Lo, et al. 2010; Mertlikova-
Kaiserova, et al. 2010; Montes, et al. 2011; Wu, et al. 2011). Seventeen cell cycle genes 
that were sensitive to the serum-free medium adaptation are listed in Table 3.  
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Table 3.3 - Cell cycle-related genes sensitive to serum-free medium adaptation process 
    Fold Change 
Gene Symbols Gene Description DP12 0/5 DP12 5/10 DHFR 5/10 
Genes sensitive to serum in both CHO cells 
Cdk6 Cyclin-dependent kinase 6 -1.6 -1.8 -1.9 
Pmp22 
peripheral myelin protein 22, 
transcript variant X2 -1.4 -1.6 -1.4 
Genes sensitive to serum in CHO DP-12 only 
Ccnd3 cyclin D3, transcript variant X1 -1.6 -1.3 
Cdkn1a 
cyclin-dependent kinase inhibitor 
1A (p21, Cip1) -1.3 -2.1 
Nek2 NIMA-related kinase 2 -1.3 -1.9 
Rb1 
retinoblastoma 1, transcript variant 
X2 -1.4 -1.3 
Stmn1 stathmin 1, transcript variant X2 -2.0 -1.2 
Genes sensitive to transition from 10% to 5% serum in both CHO cells 
Birc5 
baculoviral IAP repeat containing 
5 -1.2 -1.2 
Ccnd1 cyclin D1 -1.3 -2.7 
Cdkn1b 
cyclin-dependent kinase inhibitor 
1a 1.4 1.8 
Cdkn3 
cyclin-dependent kinase inhibitor 
3, transcript variant X4 1.4 1.2 
E2f2 
E2F transcription factor 2, 
transcript variant X2 2.0 1.4 
E2f3 
E2F transcription factor 3, 
transcript variant X3 -1.4 -1.2 
Itgb1 
integrin, beta 1 (fibronectin 
receptor) -2.6 -1.5 
Mad2l1 
MAD2 mitotic arrest deficient-like 
1 (yeast) 1.4 1.4 
Notch2 notch 2, transcript variant X2 -1.5 -1.4 
Tfdp1 
transcription factor Dp-1, 
transcript variant X6 -1.2 -1.3 
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Cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors genes 
are known to play critical role in the cell cycle progression and cell proliferation. The 
gene expression profiles for cyclin dependent kinase inhibitor genes (Cdkn1a, Cdkn1b, 
Cdkn3), and cyclin and cyclin-dependent kinase genes (Ccnd1, Ccnd3, Cdk6) are shown 
in Figure 3.5A and 3.5B, respectively. Cyclin-dependent kinase inhibitor genes encode 
for proteins that function as cell-cycle regulators by binding with the cyclin-dependent 
kinases and inhibiting its activity. Of the three cyclin-dependent kinase inhibitor genes 
that were serum sensitive, only Cdkn1a gene had significant decrease expression in 
rCHO DP-12 throughout the serum-free medium adaptation process. Cdkn1a gene is one 
of the most potent and important inhibitor of cell proliferation and the decrease in its 
gene expression could be vital in preventing cell cycle arrests during the serum-free 
medium adaptation process. For Cdkn1b and Cdkn3, there was no significant change in 
expression when transitioning from 5% serum to 0% serum. Interestingly, the expression 
of cyclins – Ccnd1 and Ccnd3, and cyclin-dependent kinase - Cdk6, had a decrease in 
expression in both CHO cell lines during the adaptation. The decrease in expression of 
these CDK and cyclin genes can impact cell cycle progression and cellular proliferation.  
The cells were well adapted to the particular serum concentration at the time of RNA 
harvest and hence it was rather surprising to see the lower expression of these genes. It 
should be noted that the mammalian cells contain 5 different CDK subunits and 10 
distinct cyclins that contribute towards cell cycle proliferation (Harper and Adams 2001). 
This could indicate that the expression of other members of CDKs and cyclins, which 
were not identified to be serum, could be important in regulating cellular proliferation. 
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Figure 3.5: Cell cycle genes sensitive to serum-free medium adaptation process. In 
particular, the serum sensitive genes belonged to: A) cyclin dependent kinase inhibitors 
and B) cyclins and cyclin-dependent kinases.  
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3.4.3.2 Apoptosis genes 
Serum withdrawal and nutrient limitations of growth factors often represents a 
change in nutrient environment leading to growth decline and in some cases, resulting in 
the activation of apoptosis (Arden and Betenbaugh 2004; Sinacore, et al. 2000). 
Apoptosis generally occurs through two different pathways – an extrinsic pathway (death 
receptor) or an intrinsic pathway (mitochondria-mediated) (Arden and Betenbaugh 2004; 
Miura, et al. 2012; Wong, et al. 2006). To investigate the impact of serum-free medium 
adaptation on apoptosis, the serum sensitive genes were compared to the 84 apoptosis 
pathway related genes compiled by SABiosciences were examined(Dutta, et al. 2012; 
Mao, et al. 2010; Taylor, et al. 2011; Wu, et al. 2011). Due to the similar nature of 
apoptosis and cell cycle activity, there were five genes were in common between the two 
lists. Of the 84 apoptosis genes, 15 genes were serum sensitive. Interestingly, the 
majority of the serum-sensitive apoptosis-related genes (9) were affected when CHO 
cells transitioned from 10% to 5% serum. Anti-apoptotic genes such as Birc3 and Cflar 
had at least 1.5-fold change in expression in both CHO cells while transitioning from 
10% serum to 5% serum (Figure 3.6A). Birc3 gene encodes for a member of the inhibitor 
of apoptosis family. However, Birc3 had decrease in expression in both CHO cell lines 
and throughout the adaptation process in CHO DP-12. The decrease in expression Birc3 
could potentially lead to unregulated expression of Casp3 and Casp7, leading to 
apoptotic cell death. Cflar acts as an inhibitor of tumor necrosis factor receptor (TNFR) 
mediated apoptosis and the lower expression of this gene has been associated with 
induction of apoptosis. Other anti-apoptotic genes such as Nol3, that also acts an 
59 
 
apoptosis inhibitor of caspase activities (Casp2, Casp8), had an increase in expression 
during the transition. The expression of these genes did not change significantly while 
adapting to 0% serum from 5% serum medium (data not shown). Pro-apoptotic genes 
such as Casp1 and Nod1 were serum-sensitive in both CHO cells (Figure 3.6B). 
Particularly, Casp1 had an increase in expression of over 30-fold as the cells transitioned 
from 5% serum to 0% serum. Casp1 has been observed to play a role in apoptosis 
induction, particularly in CD-95 mediated apoptosis. However, studies have suggested 
other caspases may play a more significant role in apoptosis pathway than Casp1 (Cohen 
1997). Nod1 gene encodes for a cytosolic protein that is involved in the apoptotic 
signaling and enhancing caspase-9-mediated-apoptosis. In this study, however, at the 
time of RNA-extraction, the cells were completely adapted to serum-free medium and the 
cells were growing exponentially and no signs of apoptosis were recorded. Generally, the 
occurrence of apoptosis has been observed during the later stages of the growth phase. It 
is likely that the expression changes of these genes may not be translated into activity in a 
linear fashion. Further studies are required at the proteome level to understand the role of 
apoptosis during the serum-free medium adaptation. 
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Table 3.4 - Apoptosis-related genes sensitive to serum-free medium adaptation process 
    Fold Change 
Gene 
Symbols Gene Description 
DP12 
0/5 
DP12 
5/10 
DHFR 
5/10 
Genes sensitive to serum in both CHO cells 
Bcl2l1 BCL2-Like 1 -1.3 -1.2 -1.3 
Birc3 
baculoviral IAP repeat containing 
3, transcript variant X2 -1.5 -2.1 -2.1 
Casp1 
caspase 1, apoptosis-related 
cysteine peptidase, transcript 
variant X1 6.0 4.7 31.6 
Casp7 
caspase 7, apoptosis-related 
cysteine peptidase, transcript 
variant X3 2.1 1.2 1.7 
Genes sensitive to serum in CHO DP-12 only 
Bnip3l 
BCL2/adenovirus E1B 19kDa 
interacting protein 3-like, 
transcript variant X2 -1.6 -1.3 
Mcl1 
myeloid cell leukemia 1, 
transcript variant X2 -2.2 -1.4 
Genes sensitive to transition from 10% to 5% serum in both CHO cells 
Akt1 
v-akt murine thymoma viral 
oncogene homolog 1, transcript 
variant X2 -1.3 -1.3 
Atf5 
activating transcription factor 5, 
transcript variant X2 -3.2 -1.2 
Birc5 
baculoviral IAP repeat containing 
5 -1.2 -1.2 
Bnip2 
BCL2/adenovirus E1B 19kDa 
interacting protein 2, transcript 
variant X2 -1.3 -1.2 
Cflar 
CASP8 and FADD-like apoptosis 
regulator, transcript variant X1 -3.1 -1.5 
Dffa 
DNA fragmentation factor, 
45kDa, alpha polypeptide, 
transcript variant X2 1.7 1.5 
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Table 3.4 - Apoptosis-related genes sensitive to serum-free medium adaptation 
process 
Nod1 
nucleotide-binding 
oligomerization domain 
containing 1, transcript variant 
X1 -1.4 1.4 2.1 
Nol3 
nucleolar protein 3 (apoptosis 
repressor with CARD domain), 
transcript variant X1 1.6 1.6 
Xiap X-Linked Inhibitor Of Apoptosis -1.6 1.7 1.3 
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Figure 3.6: Apoptosis related genes that were affected by serum-free medium adaptation 
process. Serum sensitive genes were divided into: A) Anti-apoptosis and B) pro-apoptosis 
genes.  
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3.4.4 Gene ontology Enrichment analysis 
The serum sensitive genes identified from the intersections of the three serum-
related pairwise comparisons were used for gene ontology (GO) enrichment analysis by 
GOseq software to identify biological processes that were impacted by serum-free 
medium adaptation process. Gene ontology is way to represent a gene and gene product 
properties, particularly through three domains – cellular component, molecular function 
and biological process. For GO analysis, the higher and lower expression genes were 
combined for each list before performing the enrichment analysis. For the 10,774 filtered 
genes used for differential gene expression analysis, over 45% of the genes had go terms. 
Enriched GO terms that had 5 or more genes in its category were considered to be 
meaningful. 
The GO enrichment analysis for the 467 genes that were serum sensitive in both 
CHO cell lines identified enriched genes belonging to13 different GO categories. 
However, none of these GO terms had five or more genes enriched in the category, and 
hence could not be studied. The GO enrichment analysis of the 651 genes that were 
serum sensitive only in rCHO DP-12 cells recognized genes enriched in five different GO 
categories; two GO terms had five or more genes in its category - protein transport and 
lipid metabolic process (Table 3.5). Of the 11 genes representing protein transport GO 
term, all but one gene had a decrease in expression throughout the serum-free medium 
adaptation in rCHO DP-12. Five of these genes encode for proteins that belong to the 
small GTPase family, that are known to regulate membrane trafficking. Only two genes, 
Rab43 (small GTPase family) and Rras, had a decrease in expression of greater than 1.5-
64 
 
fold in both comparisons – rCHO DP-12 0%/5% and rCHO DP-12 5%/10% (Figure 3.7). 
Rras gene codes for a protein that can increase the adhesiveness of integrins to the 
substrate (Dejgaard et al. 2008, Hood et al. 2002). The decrease of Rras could be linked 
with the transition of cells from adherent growth phenotype to suspension growth 
phenotype and the consequent decrease in cell-matrix binding. Rab43 is involved in 
anterogradte/reterograde trafficking of proteins from ER to Golgi. The decrease in Rab43 
gene expression has been observed to cause Golgi redistribution but without affecting the 
trafficking of proteins from ER to cell surface. The impact of Rab43 expression needs to 
be further investigated in relation to serum-free medium adaptation. Interestingly, the 
expression of Rab43 and Rras genes in CHO DHFR- was opposite of that observed in 
rCHO DP-12, i.e. the expression increased when transitioning from 10% serum to 5% 
serum. There were six genes in lipid metabolic process category and three genes had over 
1.5-fold change in both comparisons: rCHO DP-12 0%/5% and 5%/10%. Few of the 
genes in this group code for proteins related to patatin-like phospholipase domain 
containing protein family. The members of this family catalyze the cleavage of fatty acids 
from membrane phospholipids. However, the exact relevance of these genes with serum-
free medium adaptation was not clearly understood. 
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Table 3.5 - Enriched GO terms for genes sensitive in rCHO DP-12 only 
Gene 
Symbol 
Gene Name 
Fold Change 
DP-12 
5%/10% 
DP-12 
0%/5% 
DHFR 
5%/10% 
Protein transport (GO:0015031) 
Arf4 ADP-ribosylation factor 4 -1.3 -1.6 
 
Arl8a ADP-ribosylation factor-like 8A -1.3 -1.5 
 
Rab43 
RAB43, member RAS oncogene 
family, transcript variant X2 -1.5 -1.8 2.6 
Rab5a 
RAB5A, member RAS oncogene 
family, transcript variant X2 -1.3 -1.4 2.4 
Rab7a 
RAB7A, member RAS oncogene 
family 
-1.9 -1.4 
 
Rap1a 
RAP1A, member of RAS 
oncogene family 
-1.3 -1.2 
 
Rap1b 
RAP1B, member of RAS 
oncogene family 
-1.3 -1.3 
 
Rhoc 
ras homolog family member C, 
transcript variant X2 
-1.3 -1.8 
 
Rras 
related RAS viral (r-ras) oncogene 
homolog, transcript variant X2 
-1.6 -1.5 2.0 
Rras2 
related RAS viral (r-ras) oncogene 
homolog 2 
1.2 1.6 
 
Timm17a 
translocase of inner mitochondrial 
membrane 17 homolog A (yeast) 
-1.2 -1.3 
 
Lipid metabolic process (GO:0006629) 
Dagla 
diacylglycerol lipase, alpha, 
transcript variant X4 
-2.0 -2.8 
 
Gpcpd1 
glycerophosphocholine 
phosphodiesterase GDE1 homolog 
(S. cerevisiae), transcript variant 
X2 
1.7 1.7 
 
Plcd1 phospholipase C, delta 1 -1.6 -1.5 
 
Pnpla2 
patatin-like phospholipase domain 
containing 2 
-1.4 -1.5 2.0 
Pnpla8 
patatin-like phospholipase domain 
containing 8 
-1.5 -1.3 
 
Tecr 
trans-2,3-enoyl-CoA reductase, 
transcript variant X2 
1.6 1.6 
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Figure 3.7: Rab43 and Rras gene expression in rCHO DP-12 and CHO DHFR-. 
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In contrast to the GO analysis on the previous two lists, the GO enrichment 
analysis of the 1,288 genes that were serum sensitive in both CHO cells while 
transitioning from 10% to 5% serum recognized five or more enriched genes related to 
four different GO categories. The enriched genes were related to oxidation-reduction 
process, translation, metabolic process and cell redox homeostasis (Table 3.6). Among 
genes related to oxidation-reduction process, majority (~70%) of the genes had increase 
in expression during the transition from 10% to 5% serum in both CHO cells and around 
40% of the genes had greater than 1.5-fold change in expression in rCHO DP-12 and 
CHO DHFR-. Three genes belonging to glutathione peroxidase gene family (Gpx1, Gpx4 
and Gpx8) were enriched among the oxidation-reduction genes (Figure 3.8). Glutathione 
peroxidase is a major antioxidant enzyme that functions in the detoxification of hydrogen 
peroxide. The increase in expression of genes encoding for antioxidant enzymes could 
possibly be due to an increase in oxidative stress. This was further supported by increase 
in expression of other genes families that code for antioxidant enzymes such as 
perodiredoxin, which belonged to the cell-redox homeostasis genes. Serum reduction has 
been reported to increase cell susceptibility to oxidative stress and damage, mainly due to 
the uncontrolled cellular uptake of iron in the absence of transferrin in serum-free 
medium (Rodriguez et al. 2013, Garcia-alfonso 1996). The iron-related oxidative stress 
was further indicated through the increase in expression levels of heme oxygenase 1 
(Hmox1). Hmox1 is a heat shock protein whose expression levels are induced by heat 
shock and other physiological stresses. The presence of excess iron levels has been 
observed to increase Hmox1 levels and increase reactive oxygen species (ROS) in human 
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hepatoma cells. Moreover, the expression levels of ferritin heavy chain, which assists in 
the intracellular storage of iron, were increased in both CHO cells during the transition to 
5% serum from 10% serum. The gene expression pattern observed here indicates that the 
cells were undergoing oxidative stress, likely through the unregulated uptake of iron. 
Interestingly, several of these genes had much higher expression in CHO DHFR- than its 
expression in rCHO DP-12, possibly indicating the oxidative stress was greater in CHO 
DHFR- cells. Understanding the mechanism of action to counteract this oxidative stress 
could be critical for successful serum-free medium adaptation. In rCHO DP-12, several 
of these genes did not change in significantly when transitioning from 5% to 0% serum, 
possibly indicating the stress was reduced at the later stages of the adaptation process. 
Metabolic process GO term consisted of broad category of genes belonging to different 
cellular metabolism. Among the genes enriched in the translation GO terms, several of 
the genes had very low change in expression. Based on the expression pattern of genes 
related to the oxidative stress, we hypothesize that the initial adaptation of cells from 
10% serum to 5% serum was could be more critical than the adaptation from 5% to 0% 
serum. The changes occurring at this stage could be crucial in preparing the CHO cells 
for adaptation to lower serum concentrations in later adaptation process.  
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Table 3.6 - Enriched GO terms for significant genes between rCHO DP-12 and CHO K1-
PF during the transition from 10% serum to 5% serum 
Go Term Category 
p-value for 
Over-
representation 
Number of 
Genes in 
Category 
Effected 
Number of 
Genes in 
Category 
Cell redox 
homeostasis GO:0045454 2.56E-02 6 34 
Metabolic process GO:0008152 6.32E-05 52 383 
Oxidation-
reduction process GO:0055114 1.49E-06 36 212 
Translation GO:0006412 2.64E-06 24 158 
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Figure 3.8: Glutathione peroxidase genes in rCHO DP-12 (open) and CHO DHFR- 
(closed) during the serum-free medium adaptation process  
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3.4.5 Gene expression differences between rCHO DP-12 and CHO DHFR- related to 
serum-free medium adaptation behavior 
 Of the two CHO cell lines used in this study, the serum-free medium adaptation 
process was successful only in one - rCHO DP-12. CHO DHFR- cells were unable to 
grow beyond medium containing 5% serum medium. The identification of differences in 
gene expression between rCHO DP-12 and CHO DHFR- will aid in further understanding 
of the serum-free adaptation process and in identifying critical gene expression pattern 
necessary for successful serum-free medium adaptation process. A statistical interaction 
test was used to identify genes with varying behavior between the two cell lines during 
adaptation to 5% serum from 10% serum. For example, if a significant gene had a 
positive fold-change in this comparison, it meant that the gene expression increased 
during the transition in rCHO DP-12, while the same gene decreased in expression in 
rCHO DHFR-. In total, the interaction test identified 2,956 genes that had significant 
differences in expression patterns between rCHO DP-12 and CHO DHFR- when it 
transitioned from 10% serum to 5% serum (FDR ≤ 0.01). The GO enrichment analysis 
identified genes belonging to 12 categories to be enriched (Table 3.7). The GO terms that 
were enriched among the interaction genes included DNA replication, cell cycle arrest, 
protein transport, and cell redox homeostasis.  
DNA replication term was represented by minichromosome complex maintenance 
complex component 3 (Mcm3), nuclear factor I/A (Nfia), nuclear factor I/B (Nfib), DNA 
polymerase alpha 2 (Pola2) and replication factor c5 (Rfc5) (Figure 3.9). The three genes 
had either higher expression (Pola2, Rfc5) or did not significantly change (Mcm3) in 
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rCHO DP-12, while the same genes had significantly lower expression (Mcm3, Pola2) or 
did not increase in expression (Rfc5) in CHO DHFR- when they transitioned from 10% to 
5% serum. The genes are involved in different aspects of DNA replication and cellular 
proliferation such as initiation (Mcm3), elongation (Rfc5) and replication (Pola2). 
Specifically, Mcm3 is a subunit of the MCM complex that are involved in the initiation 
and regulation of DNA replication. The decrease in Mcm3 expression levels was 
correlated with growth-arrest in human cell lines (Lee 2010). Rfc5 interacts with 
proliferating cell nuclear antigen (PCNA) to form a complex that is required for 
elongation by DNA polymerase delta and DNA polymerase epsilon. As noted earlier, 
several genes related to oxidative stress were differentially expressed during the serum-
free medium adaptation process. The cell cycle related genes were cyclin-dependent 
kinase inhibitor 1a (Cdkn1a), senstrin 2 (Sesn2) and growth arrest specific (Gas2). The 
difference in expression of Cdkn1a has already been discussed in the cell cycle genes 
section. Sesn2 expression decreased in rCHO DP-12, while it remained the same in CHO 
DHFR-. Increase in Sesn2 expression has been observed under oxidative stress. Gas2 had 
an increase in expression rCHO DP-12, while the expression of Gas2 decreased in CHO 
DHFR-. Jaluria et al. (2008) overexpressed Gas6 gene to successfully adapt the HEK-293 
cells to serum-free medium. The cell redox homeostasis GO term further indicates the 
differences in oxidative response between the two CHO cell lines. Specifically, the genes 
belonging to thioredoxin family had difference in behavior between the two CHO cell 
lines, in addition to the peroxidasin genes previously.   
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The difference in expression of almost 3,000 genes between rCHO DP-12 and 
CHO DHFR- during the transition from 10% serum to 5% serum further reinforces the 
notion that each cell line responds in a unique manner to the serum-free medium 
adaptation process. Further systems level analysis are required in addition to the work 
here to completely characterize the serum-free medium adaptation process in CHO cells.  
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Table 3.7 - Enriched GO terms among genes with expression differences between rCHO 
DP-12 and CHO K1-PF during the transition from 10% serum to 5% serum 
Go Term Category 
p-value for 
Over-
representation 
Number of 
Genes in 
Category 
Effected 
Number 
of Genes 
in 
Category 
ATP synthesis coupled 
proton transport GO:0015986 0.01 10 32 
Cell cycle arrest GO:0007050 0.05 5 12 
Cell redox homeostasis GO:0045454 0.03 10 34 
DNA replication GO:0006260 0.05 13 40 
Glycolytic process GO:0006096 0.03 6 15 
Metabolic process GO:0008152 0.01 87 383 
Nucleotide-excision repair GO:0006289 0.02 5 10 
Protein transport GO:0015031 0.03 32 146 
Proteolysis involved in 
cellular protein catabolic 
process GO:0051603 0.04 5 18 
Translation GO:0006412 0.00 57 158 
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Figure 3.9: Differences in expression DNA replication related genes between rCHO DP-
12 and CHO K1-PF. Abbreviations: Nfia – Nuclear factor I/A, Nfib – Nuclear factor I/B, 
Pola2 – DNA Polymerase alpha 2, Rfc5 – Replication factor C5.   
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3.5 Conclusions 
 Serum is an integral component of most primary animal cell culture medium. It 
provides several nutrients such as growth factors, vitamins and trace elements; however, 
it is undefined in nature and a potential source of contamination. In part due to these 
disadvantages, the use of serum in industrial mammalian cell culture processes is highly 
discouraged due to regulatory and contamination concerns. Hence, recombinant CHO cell 
lines commonly undergo adaptation to the serum-free medium. In this study, two CHO 
cell lines – a recombinant IgG1 producing rCHO DP-12 cell line and the non-recombinant 
parental CHO DHFR- cell line, were attempted to be adapted to serum-free medium. As 
has been reported in the literature and observed previously by our group with non-
recombinant CHO cell lines, the CHO DHFR- (non-recombinant) cell line was much 
slower to adapt at every stage, and in this prescriptive adaptation approach, it failed to 
progress beyond 5% serum medium. Conversely, rCHO DP-12 cell line adapted to 
serum-free medium within 65 days, yet the rCHO DP-12 cells took the longest to adapt to 
5% serum medium. In order to characterize this bottleneck point, RNA samples from 
these two CHO cell lines representing different stages of the adaptation process were 
sequenced using the next-generation RNA-Seq method. Serum sensitive genes that were 
commonly affected between the two CHO cell lines were identified and used to analyze 
the impact of serum-free medium adaptation process. Among the glycosylation genes, 
sialidase 2 decreased in expression by over 300-fold throughout the adaptation process 
and sialyltrasnferase (ST3Gal) genes were increased in expression, which correlates with 
the previous observation in literature on increase in sialic acid residues when cells were 
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cultured in serum-free medium. However, this was largely attributed to the decrease in 
concentration of serum sialidases; but this study points out that the change occurs at gene 
expression level too. Several cell cycle and apoptosis genes were sensitive to serum-free 
medium adaptation process. Notably, cyclin-dependent kinase inhibitor 1a, Cdkn1a, had a 
decrease in expression throughout the serum-free medium adaptation process in rCHO 
DP-12. Among the apoptosis genes, an increase in expression of several pro-apoptotic 
genes was such as Casp1 was observed and decrease in expression of anti-apoptotic 
genes such as Birc3 was observed. This was particularly surprising as the RNA samples 
were extracted from the mid-exponential growth phase during which the chances of 
occurrence of apoptosis is minimal. A gene ontology enrichment analysis identified genes 
related to oxidative stress enriched in both cell lines during the transition from 10% 
serum to 5% serum. Several genes coding for antioxidant enzymes had increased 
expression at 5% serum in comparison to the 10% serum, indicating that the cells might 
be experiencing oxidative stress. The source of stress is likely due to the unregulated 
uptake of iron, in the absence of transferrin in the serum-free medium. Additionally, 
several genes families had differences in response between the two CHO cell lines during 
the transition from 10% to 5% serum. Almost 3,000 genes had differences in behavior 
between the two cell lines, indicating that the response of each cell line to serum-free 
medium adaptation is unique. The GO categories enriched among these genes included 
DNA replication, cell cycle genes, cell redox homeostasis and protein transport genes.  
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CHAPTER FOUR 
IMPACT OF LOW CULTURE TEMPERATURE AND LOW INITIAL MEDIA PH ON 
CHINESE HAMSTER OVARY (CHO) CELL LINES: A TRANSCRIPTOMIC 
PERSPECTIVE USING RNA-SEQ 
 
4.1 Abstract 
Recombinant protein therapeutics’ are increasingly administered in the treatment of 
several life-threatening diseases including cancer. Chinese Hamster Ovary (CHO) cells 
are an important biopharmaceutical cell line, used in the production of over 70% of the 
approved protein therapeutics. However several limitations exist with the use of CHO 
cell lines including low product titers/productivity. Often times, protein productivity and 
culture longevity are improved by shifting to a lower process temperature. However the 
exact mechanisms through which such manipulations impact the cells are currently 
unknown. Transcriptomics is one such medium through which cellular mechanisms could 
be better understood by measuring gene expression. Recently, CHO cell transcriptomics 
has been encouraged with the establishment of Chinese hamster and CHO cell draft 
genomes. In this study, comprehensive transcriptomic analysis using RNA-seq of two 
CHO cell lines, a recombinant and a non-recombinant one, was performed to understand 
and identify key CHO cell genes involved during the low temperature treatments (33°C). 
Samples for RNA-seq were taken from the mid-exponential growth phase and sequenced 
by HiSeq 2000. The sequenced sample contained over 15 million short reads, which were 
assembled together with the CHO-K1 reference genome (v1.01). Comparison of the gene 
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expression profiles of the CHO cell lines at 33°C and 37°C (control) revealed, in 
common, 336 genes had higher expression and 39 genes had lower expression in the low 
temperature culture (filter criteria were a minimum of two-fold expression change and 
FDR ≤ 0.05). Genes such as Slc35d1 and Slc35d2, which are involved in the transport of 
nucleotide sugars, were found to have higher expression at lower temperatures. This 
could provide a possible explanation for the improvement in protein productivity 
observed at low temperature treatments.  
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4.2 Introduction 
 CHO cells are widely used in the biopharmaceutical industry, particularly in the 
manufacture of recombinant therapeutics such as antibodies, interferons, blood factors 
and growth factors(Butler and Meneses-Acosta 2012; Datta, et al. 2013; Kantardjieff and 
Zhou 2013; Omasa, et al. 2010). It is estimated that more than 60% of the recombinant 
protein therapeutics are produced using CHO cells, accounting for more than $100 billion 
in global revenues(Bandaranayake and Almo 2013; Jayapal, et al. 2007; Kantardjieff and 
Zhou 2013). Despite the availability of several mammalian cell line options, CHO cells 
are selected for use due to several advantages over other cell lines, including easy scale 
up to large-scale processes, well-developed transfection systems for easy recombinant 
protein expression and the ability to perform compatible protein post-translational 
modifications(Kim, et al. 2012; Omasa, et al. 2010; Wuest, et al. 2012). 
In industry, it is a common practice to lower the culture temperature after an 
initial growth phase in order to improve culture viability, as well as increase recombinant 
protein yield and productivity relative to the original higher culture temperature(Fogolı́n, 
et al. 2004; Fox, et al. 2004; Kaufmann, et al. 1999; Kou, et al. 2011; Trummer, et al. 
2006; Yoon, et al. 2003a; Yoon, et al. 2003b). Unfortunately, the impact of reducing the 
culture temperature on protein productivity is highly cell line and recombinant protein 
specific. For example, several research groups have observed decreased or no change in 
specific protein productivity after reducing the culture temperature for CHO cells and 
other related mammalian cell lines (Yoon 2003antibody, Sureshkumar 1991, Barnabe 
1994, Weidemann et al. 1994, Reuveny et al. 1986, Fox et al. 2004). In contrast, other 
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research groups have reported substantial protein productivity improvements after 
reducing the culture temperature(Fogolı́n, et al. 2004; Furukawa and Ohsuye 1998; 
Kaufmann, et al. 1999; Yoon, et al. 2003b). Kantardjieff et al. (2010) used DNA 
microarrays to assess gene expression changes in CHO cells under low temperature and 
sodium butyrate treatment. They identified that cell cycle and growth factor related genes 
had lower expression at low culture temperatures while extracellular matrix and fatty acid 
metabolism genes had higher expression at the low culture temperatures. Unfortunately, 
they used a proprietary DNA microarray in this study making it difficult to utilize these 
findings, as the gene sequences were not made publicly available. As these previous 
studies have identified a confounding effect of temperature and productivity. 
Another important cell culture environmental factor that affects the protein 
productivity is the culture pH. Specifically, CHO cells grown at low pH have been 
improved cell viability, prolonged cultivation time and enhanced recombinant protein 
yield (Trummer 2006, Yoon 2005, Miller 1988). Much of these improvements have been 
attributed to decreased glucose consumption and lactate production rates (Yoon 2005). 
Additionally, variations in pH can also influence glycosylation, a key post-translational 
modification that influences protein efficacy (Borys 1993, Borys 1994, Yoon 2006, 
Hayter 1993).  
To further elucidate the mechanism of pH effect on glycosylation and other 
culture parameters, transcriptome understanding of the pH influence on CHO cell culture 
is necessary. Despite being one of the most basic and critical parameters, currently there 
are no known transcriptome studies in literature understanding the response of CHO cells 
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to extracellular pH variations. In this study, high-throughput, next-generation 
transcriptomic technology, RNA-Seq, was utilized to understand the impact of 
temperature and pH on two CHO cell lines– a recombinant CHO DP-12 cell line and a 
non-recombinant CHO K1-PF cell line. The objective of the investigation was to shed 
light on temperature and pH related effects, such as productivity improvements, high cell 
viability and low waste production, by characterizing the impact on CHO cell 
transcriptome.  
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4.3 Materials and Methods 
4.3.1 CHO Cell Lines 
Two CHO cell lines were used in this study: 1) rCHO DP-12, clone #1934 
(ATCC® CRL-12445™), a recombinant CHO cell line expressing a human monoclonal 
antibody against Interluekin-8 (IL-8), and 2) CHO K1-PF (Sigma 00102307), a non-
recombinant CHO cell line derived from CHO-K1 and previously adapted to Sigma CHO 
protein-free medium (TT Puck et al. 1958 Genetics of somatic cells III). The rCHO DP-
12 cell line was adapted to serum-free, protein-free, chemically defined CD CHO 
medium (Life technologies, NY, USA) as described previously (Gowtham serum-free 
adaptation). The CHO K1-PF cell line was also adapted to grow in CD CHO medium. 
Anti-clumping agent (Life technologies, NY, USA) was added (1:250) to the medium to 
prevent cell clumping in suspension cultures. 
 
4.3.2 Culture Conditions 
CHO cell cultures were seeded at ~ 9.0 X 104 cells/mL in 75 cm2 flasks (Corning 
Inc, NY, USA) and grown in humidified incubators maintained at 37°C or 33°C with 5% 
CO2 atmosphere. The initial culture pH measured in CD CHO medium in 5% CO2, 
humidified incubator was 6.95 and no alterations were made to it. To assess the impact of 
low pH on CHO cell transcriptome, the initial media pH was reduced to 6.70 using 1.2N 
HCl (Thermo Fisher Scientific, NC, USA). CD CHO medium was supplemented with 
5mM glutamine and anti-clumping agent (Life technologies, NY, USA) was added 
(1:250). The initial pH and the pH the time of RNA extraction was measured using a 
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Denver Instruments UltraBasic benchtop pH meter UB-10. Samples were taken every 24 
hours for cell concentration and viability, glucose and lactate concentrations. Cell 
concentrations and viabilities were measured using Bio-Rad TC20™ Automated Cell 
Counter (Bio-Rad Laboratories, CA, USA). Glucose and lactate concentrations were 
obtained using a Yellow Springs Instruments (YSI) 2900 Biochemistry Analyzer (Yellow 
Springs, OH, USA). For each cell line, all four combinations of the two culture 
temperatures (37°C or 33°C) and two initial culture pH values (6.95 and 6.70) were 
examined. Duplicate cultures were conducted for all conditions examined. Statistical 
analysis to find differences in growth rates was performed using JMP software (SAS 
institute, NC, USA). 
 
4.3.3 Transcriptome Analysis 
For transcriptome analysis, RNA samples were extracted after the CHO cells 
reached a minimum cell concentration (> 2.0 X 105 cells/mL). To collect mRNA samples, 
RNAprotect® cell reagent (Qiagen, Valecia, CA) was added to a harvested sample 
immediately upon withdrawal from the flask. Total RNA extraction was performed as per 
RNeasy Plus Mini kit (Qiagen) protocol. Total RNA was extracted into 1.5 mL RNAase-
Free, DNAase-Free tubes and stored in -80°C until required. A NanoDrop 8000 UV-Vis 
spectrophotometer (Thermo Scientific, MA, USA) and Agilent 2100 Bioanalyzer System 
(Agilent, Santa Clara, CA) with RNA 6000 Nano kit (Aglient) were used to confirm the 
quality of the extracted total RNA samples. All samples had RNA integrity numbers 
(RIN) values of greater than nine. 
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4.3.4 Library Synthesis, Sequencing and Reference Mapping 
The cDNA libraries for whole transcriptome sequencing for each sample were 
constructed by following the recommended protocol of the TruSeq RNA sample 
preparation v2.0 kit (Illumina, San Diego, CA). Briefly, messenger RNA (mRNA) was 
enriched from total RNA using poly-T magnetic beads. Next, mRNA was cleaved into 
fragments by a non-specfic RNA endonuclease and the fragmentation products were 
synthesized into complementary DNA (cDNA) using reverse transcriptase and DNA 
polymerase enzymes, respectively. The cDNA products then underwent an end repair 
process to flush, A-tail, and phosphorylate the DNA ends. These products were then 
ligated to adapters that serve as priming sites for enrichment by PCR to create the cDNA 
libraries for sequencing. Each library contains an individual specific DNA index that is 
used for multiplexing during massively parallel sequencing. The resulting cDNA libraries 
were quality validated on an Agilent 2100 Bioanalyzer System to ensure proper fragment 
distribution (~260 bp) and effective removal of adapter dimers. Sequence libraries were 
multiplexed and sequence data collected on 2 lanes of a HiSeq 2500 (Illumina, San 
Diego, CA) at the Genomics division of David H. Murdock Research Institute 
(Kannapolis, NC) using a 2×101 bp, paired end read type. Raw sequence reads were 
demultiplexed on the instrument and reads greater than or equal to 36 bp were cleaned of 
adapter and low quality bases (less than Phred 15) with the Trimmomatic software 
package (Bolger, et al. 2014). 
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The trimmed reads obtained were mapped on to the Chinese hamster reference 
genome sequence with the Subread Aligner (v1.4.5) (Liao, et al. 2013b). Subread 
performed local alignment of the reads and reported the locations that have the largest 
overlap among the reads. FeatureCounts was used to assign the reads to the target genes 
and summarize the data into a read counts table (Liao, et al. 2013a). This table was 
subsequently used as input in the differential gene expression analysis.  
 
4.3.5 Differential Gene Expression Analysis and Gene Ontology Analysis 
Differential gene expression analysis of the RNA-Seq data used the edgeR 
software package for data filtering and statistical analysis (Robinson, et al. 2010). The 
software edgeR utilizes a negative binomial distribution model to capture the quadratic 
mean-variance relationship common to RNA-Seq data (Chen, et al. 2014; Robinson and 
Smyth 2008). Additionally, edgeR employs an empirical Bayes method to stabilize over-
dispersion across genes by sharing information across all observations including 
replicates (McCarthy, et al. 2012; Robinson and Smyth 2007; Robinson, et al. 2010). The 
steps used for RNA-Seq statistical analysis were a) filtering low expressed genes, b) 
normalizing the library, c) plotting the multidimensional scaling graph, d) identifying 
differentially expressed genes using generalized linear model and e) analyzing genes for 
overrepresentation by gene ontology (GO) using GOseq. The raw data was mapped to 
27,629 genes in the Chinese hamster reference genome (Lewis et al.). An independent 
gene filtering criteria of 10 count-per-million (cpm) in at least two samples was used to 
remove genes with low expression (Anders, et al. 2013). The library sizes for all samples 
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were normalized using trimmed mean of M-values (TMM) method in edgeR (Robinson 
and Oshlack 2010). Multidimensional scaling (MDS) plot was used to visualize the 
similarities and dissimilarities between the replicates and samples (Appendix B.2, B.3). 
Additionally an estimation of tagwise dispersion related to the design matrix was 
conducted using the quantile-adjusted conditional maximum likelihood (qCML) method 
(McCarthy, et al. 2012). To identify the differentially expressed genes, one-way layout 
was used for pairwise comparisons between the different conditions. A Benjamini-
Hochberg procedure was used to control for false discovery rates (FDR) and FDR ≤ 0.01 
was used, unless otherwise specified (Benjamini and Hochberg 1995). The differentially 
expressed genes were used for gene ontology enrichment analysis using the goseq 
software – a R based Bioconductor package (Young, et al. 2012). GOseq accounts for 
selection bias for long and overexpressed gene sequences by calculating the Probability 
Weighting Function (PWF) (Oshlack and Wakefield 2009). For GO analysis, goseq uses 
two vectors – one containing all the measured genes and the other containing the 
differentially expressed genes. Additional information containing genes length and the 
GO categories associated with the genes were supplied. GO terms with p ≤ 0.05 from the 
over-representation test were considered to be statistically significant. Additionally, 
manual screening of gene and gene families, that had common stem in its gene symbol, 
with greater than 1.5-fold expression change was performed to identify genes sensitive to 
serum-free medium adaptation process. 
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4.4 Results and Discussion 
The effects of temperature and pH on protein productivity proved to be cell line 
and recombinant protein specific. In order to address this potential issue, two CHO cell 
lines were used. In order to isolate the temperature and pH effect on gene expression, two 
CHO cell lines used were a recombinant CHO cell line (rCHO DP-12) and a non-
recombinant cell line (CHO K1-PF). CHO K1-PF represents a parental cell line of rCHO 
DP-12; however these cell lines have been separated for a couple decades (Hamillton and 
ham, et al. 1998). CHO K1-PF was adapted to serum-free medium by Hamilton and ham 
et al. (1978) and then to CD CHO medium for this study. While the rCHO DP-12 cell 
lines was adapted to serum-free, protein-free CD CHO medium in a previous study 
(Gowtham et al. 2016). Thus, both CHO cell lines were cultured in the same chemically 
defined, protein-free, serum-free medium (CD CHO medium). The two CHO cell lines 
were cultivated at two culture temperatures – control (37°C) and low (33°C) 
temperatures, and the two initial media pH – control pH (6.95) and low pH (6.70). The 
study consisted of a full factorial model of three factors with two levels each resulting in 
eight different conditions.  The cells were seeded at very low cell concentrations, such 
that the pH did not significantly change during the course of the experiment. 
Additionally, the utilization of the low cell concentrations minimized the glucose and 
waste product concentration changes over the course of the experiment.  
Figure 1 shows the growth profiles for all the rCHO DP-12 and CHO K1-PF 
cultures. As expected, the 37°C cultures had significantly higher growth rates than the 
33°C cultures (P ≤ 0.05) (Table 1). The rCHO DP-12 had slightly higher growth rates for 
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conditions compared to the CHO K1-PF (P ≤ 0.05). Unexpectedly, the growth rates were 
not affected with respect to culture pH for both CHO cell lines (P ≤ 0.05). Figure 2 shows 
the glucose and lactate concentrations profiles for both cell lines. The glucose 
concentrations are nearly unchanged up to the time of RNA harvesting. The lactate 
concentration at the time of the RNA harvest is very low, less than 4mM for all samples. 
As expected, the low pH culture have lower lactate accumulation relative to the normal 
pH culture for both cell lines at both 37°C and 33°C. 
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Table 4.1 - Growth rates for all rCHO DP-12 and CHO K1-PF cultures grown at different culture 
temperature and different initial media pH. Errors represent 95% confidence intervals. 
Cell Lines pH 
Temperature 
37°C 33°C 
rCHO DP-12 
Control pH 0.035 ± 0.001 0.016 ± 0.001 
Low pH 0.034 ± 0.001 0.014 ± 0.001 
CHO K1-PF 
Control pH 0.029 ± 0.001 0.010 ± 0.001 
Low pH 0.029 ± 0.001 0.01 ± 0.001 
 
  
91 
 
 
 
Figure 4.1: Growth profiles for rCHO DP-12 and CHO K1-PF cultures at low 
temperature and low pH conditions. A) rCHO DP-12 and B) CHO K1-PF were grown at 
37°C (circles) and 33°C (squares) and pH 6.95 (closed) and pH 6.70 (open). Black circles 
indicate the time at which RNA samples were harvested.  
   
 
 
 
 
A 
B 
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Figure 4.2: Glucose and lactate concentration profiles for rCHO DP-12 and CHO K1-PF 
cultures. Glucose (Top) consumption profiles and lactate (bottom) production profiles are 
shown for rCHO DP-12 (left) and CHO K1-PF (right) grown at 37°C (circles) and 33°C 
(squares) and pH 6.95 (closed) and pH 6.70 (open). Black circles indicate the time at 
which RNA samples were harvested.   
DP-12 
  
K1-PF 
  
K1-PF 
  
DP-12 
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4.4.1 Transcriptome analysis of CHO cell lines 
 RNA samples were extracted from the both CHO cell lines at a minimum of 2 X 
105 cells/mL concentration and > 95% viability, at the time points indicated by arrows in 
Figure 1. At the time the RNA samples were taken, the glucose concentration for all 
cultures was above 30 mM and the lactate concentrations were below 4 mM, indicating 
the cells had sufficient glucose and the cultures were not lactate inhibited (Lu, et al. 
2005). The cultures continued past the RNA harvest time point to demonstrate that all 
cultures were in mid-exponential growth phase. The libraries for both replicates of CHO 
K1-PF cells grown at 37°C and 6.70 pH was lost due to contamination and were not used 
in the statistical analysis. Due to the unbalanced nature of the data, a one-way layout was 
used for the differential gene expression analysis. The number of differentially expressed 
genes in all pairwise comparisons performed between rCHO DP-12 and CHO K1-PF 
cultures are shown in Table 2 (FDR ≤ 0.01). The pairwise comparisons with pH as the 
main effect had consistently much lower number of significant genes for both CHO cell 
lines than the comparisons with temperature or cell lines as the main factors. Specifically, 
the comparison of low pH and control pH cultures for rCHO DP-12 cells and CHO K1-
PF cells at 33°C resulted in 21 genes and 28 genes with differential expression, 
respectively. Furthermore, the number of differentially expressed genes in these 
comparisons is much lower than the number of false positive genes expected in a 
comparison involving 11,000 genes at FDR ≤ 0.01. Due to the minimal impact of pH on 
the transcriptomes of rCHO DP-12 and CHO K1-PF in this study, a new model with only 
cell line and temperature as the two factors was subsequently used. The pairwise 
94 
 
comparisons for rCHO DP-12 and CHO K1-PF using the new two-factor model are 
shown in Table 3 (FDR ≤ 0.01). The pairwise comparisons with temperature as the main 
effect for rCHO DP-12 and CHO K1-PF were used to assess the impact of temperature 
on CHO cell transcriptome. Around 4,500 genes in rCHO DP-12 and around 5,000 genes 
in CHO K1-PF were sensitive to the changes in culture temperature. The overlap of the 
3,186 differentially expressed genes in rCHO DP-12 and CHO K1-PF was used for 
further analysis. Specifically, 1,719 genes with higher expressed and 1,467 genes with 
lower expression were commonly affected by temperature in the two CHO cell lines 
(Figure 4.3). These common genes were used for further analysis of the impact of 
temperature on functional groups such as glycosylation, apoptosis, and cell cycle, in 
addition to gene ontology enrichment analysis. 
  
95 
 
 
 
Figure 4.3: Temperature sensitive genes for rCHO DP-12 and CHO DHFR- were 4565 
and 5222 genes, respectively. Temperature sensitive genes that had A) higher expression 
and B) lower expression temperature sensitive genes between rCHO DP-12 and CHO 
DHFR-  
96 
 
Table 4.2 - Pairwise comparisons of rCHO DP-12 and CHO K1-PF cultured at different temperatures and initial media pH 
(FDR ≤ 0.01). There were 11,016 genes using for the comparison. Numbers in parenthesis indicated the number of genes with 
greater than 1.5-fold change in expression 
Cell 
Lines 
    rCHO DP-12 CHO K1-PF 
Temperature   37°C 33°C 37°C 33°C 
pH 
Control 
pH 
Low 
pH 
Control 
pH 
Low 
pH 
Control 
pH 
Low 
pH 
Control 
pH Low pH 
rCHO 
DP-12 
37°C 
Control 
pH 
151 
(39) 
3176 
(1091) 
3669 
(1303) 
6157 
(3405) 
7101 
(4408) 
7246 
(4625) 
Low pH 
3149 
(1072) 
3380 
(1149) 
6170 
(3361) 
7083 
(4378) 
7235 
(4578) 
33°C 
Control 
pH 21 (14) 
6650 
(3929) 
6221 
(3426) 
6374 
(3642) 
Low pH 
6697 
(3895) 
6214 
(3214) 
6251 
(3521) 
CHO 
K1-PF 
37°C 
Control 
pH 
4637 
(1985) 
5271 
(2497) 
Low pH 
33°C 
Control 
pH 
28 
(14) 
Low pH 
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Table 4.3 - Pairwise comparisons of rCHO DP-12 and CHO K1-PF cultured at different 
temperatures (FDR ≤ 0.01). There were 11,016 genes using for the comparison. Numbers in 
parenthesis indicated the number of genes with greater than 1.5-fold change in expression. The 
numbers in bold represent comparisons with temperature as the main factor and the numbers 
in italics represent comparisons with cell line as the main factor. 
Cell Lines   rCHO DP-12 CHO K1-PF 
Temperature 37°C 33°C 37°C 33°C 
rCHO DP-12 
37°C 
4565 
(1045) 
6420 
(3340) 
8043 
(4474) 
33°C 
6909 
(3767) 
7280 
(3461) 
CHO K1-PF 
37°C 
5222 
(2186) 
33°C 
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4.4.2 Impact of low temperature on glycosylation related genes 
 Glycosylation is a critical post-translational modification involving the addition of 
carbohydrate moieties on the nascent protein inside the Golgi apparatus. For therapeutic 
proteins, glycosylation is often critical to determining efficacy, immunogenicity, and 
stability of the protein (Walsh et al. 2004). In biopharmaceutical industry, obtaining a 
consistent glycosylation profiles is necessary for regulatory approval. Factors that change 
glycosylation related gene expression would most likely impact protein glycosylation. In 
this study, the impact of culture temperature on glycosylation was investigated by 
characterizing gene expression changes for the 300 glycosylation-related genes. The 
initial glycosylation list of 298 genes was obtained from Xu et al. The gene list was 
compared with the temperature sensitive genes in rCHO DP-12 and CHO K1-PF. 
However, it was noticed that 34 glycosylation genes from Xu et al. did not map to the 
Chinese hamster reference genome. The Ensemble gene IDs corresponding to the 
unmapped genes were used to investigate the identity of these genes in Chinese hamster 
genome. Using the Ensemble IDs, the nucleotide sequence was obtained and used in 
CHOblast search tool (www.chogenome.org) against CH_RefSeq_2014 database to find 
the positioning of the unmapped genes on the Chinese hamster genome scaffolds. The 
position coordinates were used in the Chinese hamster genome viewer to visualize the 
gene (www.chogenome.org). Several genes were labeled as LOCs genes, indicating that 
these genes are not functionally characterized. The corrected glycosylation list containing 
264 genes is provided in the supplementary. Additionally, few genes names were also 
updated. Of the 264 genes, 62 glycosylation genes were sensitive to temperature in both 
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rCHO DP-12 and CHO K1-PF. The majority (> 80%) of these genes had an increase in 
expression in both CHO cells cultured at low temperature. Many of the gene expression 
changes were very small change and likely had little effect on the overall protein 
glycosylation. If just the genes that changed more than 1.5-fold in expression were 
examined, several important protein glycosylation genes had differential expression; 
specifically Neuaminidase genes – Neu1 and Neu2, and nucleotide sugar transporters 
Slc35d1 and Slc35d2 (Table 4). The fold changes of the genes due to temperature are 
shown in Figure 4.4 and 4.5. Neu1 and Neu2 are two of the four characterized 
mammalian sialidases, which catalyze the removal of sialic acids from glycoproteins 
(Miyagi and Yamaguchi 2012). Neu2 expression was lower, while Neu1 expression was 
higher for the 33°C culture relative to the 37°C culture for both CHO cell lines. 
Interestingly, the baseline Neu1 expression is much higher than Neu2 in both cell lines. 
The higher expression of Neu1 is likely to result in the overall increase in sialidase 
enzyme activity and greater degradation of sialic acid at lower culture temperature. 
Moreover, Neu3 had a significant increase in expression in CHO K1-PF but not in rCHO 
DP-12 (FDR ≤ 0.01). In IgG-based therapeutics, the presence of terminal sialic acids on 
the glycosylated protein has been observed to reduce antibody-dependent cellular 
cytotoxicity (ADCC) and mediate anti-inflammatory response(Costa, et al. 2013). 
Slc35d1 and Slc35d2 encode nucleotide sugar transporter proteins that are used to 
transport nucleotide sugars from cytosol into the endoplasmic reticulum (ER) and Golgi 
apparatus. Specifically, Slc35d1 transports UDP-glucuronic acid (UDP-GlcA) and UDP-
N-Acetylgalactosamine (UDP-GalNAc), while Slc35d2 transports UDP-N-
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Acetylglucosamine (UDP-GlcNAc). Slc35d1 and Slc35d2 had increase in expression of 
over 2-fold at lower temperature for both CHO cell lines. The overexpression of Slc35d1 
in yeast cells resulted in increased in the translocation of UDP-GlcA and UDP-GalNAc 
in to the ER (Muraoka, et al. 2001). The core glycan structure in N-linked glycosylation 
is made up of two N-acetylglucosamine. Additionally, the complex type of N-glycans 
contains one or two more N-acetylglucoseamine in its structure. The increase in 
nucleotide sugar transporters in the ER/Golgi can directly improve the availability of the 
critical sugar residue, N-acetylglucoseamine, and thereby improving protein 
glycosylation. 
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Table 4.4 - Glycosylation genes that were temperature sensitive with more than 1.5-fold 
change in both rCHO DP-12 and CHO K1-PF (FDR ≤ 0.01) 
Fold Change 
Gene 
Symbol Gene Family rCHO DP-12 CHO K1-PF 
ARSA Arylsulfatases 1.5 2.4 
Csgalnact2 GalNAc-transferases 1.5 1.6 
EXTL1 GlcNAc-transferases 2.0 1.8 
UGGT2 Glucosyltransferases 2.0 2.1 
UGCG Glucosyltransferases 1.6 2.1 
IDUA Iduronidases 1.9 2.5 
NAGA Lysosomal Enzymes 1.7 1.7 
CTBS Lysosomal Enzymes 1.5 2.0 
GBA Lysosomal Enzymes 1.5 2.2 
MAN2B1 Mannosidase 1.5 1.7 
ALG9 Mannosyltransferases 1.6 1.8 
SLC35D1 Nuc. Sugars Transporters 2.1 2.0 
SLC35D2 Nuc. Sugars Transporters 2.0 3.4 
TSTA3 Nucleotide Synthesis  1.6 2.1 
UAP1 Nucleotide Synthesis  -1.5 -1.6 
Neu1 Sialidases 1.8 2.6 
Neu2 Sialidases -3.5 -3.0 
SULF2 Sulfatases 3.2 91.4 
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Figure 4.4: Temperature sensitive glycosylation related genes. Normalized expression 
levels of sialidase genes – Neu1, Neu2 and Neu3 in rCHO DP-12 and CHO K1-PF 
cultured at 33°C and 37°C. Neu3 had no significant change in expression in rCHO DP-
12, as indicated by #.   
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Figure 4.5: Temperature sensitive glycosylation related genes. Normalized expression 
levels of Nucleotide sugar transporters A) Slc35d1 and B) Slc35d2 in rCHO DP-12 and 
CHO K1-PF cultured at 33°C and 37°C.  
A 
B 
104 
 
4.4.3 Impact of low temperature on cell cycle genes 
 Cell cycle genes that belonged to various cell cycle phases such as G-phase, M-
phase, S-phase and DNA replication genes, as well as regulation related genes such as 
cell cycle checkpoint, cell cycle arrest and progression of cell cycle were examined. In 
this study, the temperature sensitive genes were compared to 84 cell cycle related genes 
that were compiled by SABiosciences (Fischer, et al. 2011; Montes, et al. 2011; Wu, et 
al. 2011). Of the 84 cell cycle genes, there were 11 temperature sensitive genes that had 
more than 1.5-fold change in expression (Table 5). The temperature sensitive genes 
included cyclin-dependent kinase inhibitors (Cdkn1a, Cdkn3), cyclins (Ccna2, Ccnb1) 
and mini chromosome maintenance gene (Mcm3) (Figure 4.6). Cyclin-dependent kinase 
inhibitor genes encode for proteins that bind to and inhibit the activity of cyclin-cylin-
dependent kinases complexes, thereby inhibiting cellular proliferation. Interestingly, 
cyclin-dependent kinase inhibitor, Cdkn3, had a decrease in expression at lower culture 
temperature in both rCHO DP-12 and CHO DHFR-. In contrasts, Cdkn1a had over two-
fold increase in expression at lower culture temperature in both CHO cells, indicating that 
the cellular proliferation was inhibited at lower temperature primarily through Cdkn1a. 
Cyclins, Ccna2 and Ccnb1, which are essential for the cell cycle progression from G1/S 
phase and G2/M phase, had a decrease in expression at 33°C relative to 37°C; further 
contributing towards slow growth rates at low culture temperature. The results are 
consistent with the observations of Moore et al. (1997) who observed an increase in 
proportion of cells in G1 phase when the culture temperatures were shifted. 
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Table 4.5 - Cell cycle genes with more than 1.5-fold change that were temperature 
sensitive in both rCHO DP-12 and CHO K1-PF 
Fold Change 
Gene 
symbol Gene name 
rCHO DP-
12 
CHO K1-
PF 
Aurka aurora kinase A -1.6 -2.2 
Aurkb aurora kinase B, transcript variant X2 -1.5 -2.7 
Casp3 Caspase 3 2.0 1.8 
Ccna2 cyclin A2 -1.5 -2.5 
Ccnb1 cyclin B1, transcript variant X2 -1.7 -2.4 
Cdc6 Cell division cycle 6 -1.7 -2.3 
Cdkn1a cyclin-dependent kinase inhibitor 1A (p21, Cip1) 4.1 4.3 
Cdkn3 
cyclin-dependent kinase inhibitor 3, transcript 
variant X4 -1.7 -2.7 
Mcm3 
minichromosome maintenance complex 
component 3, transcript variant X2 -1.5 -1.8 
Mdm2 
MDM2 oncogene, E3 ubiquitin protein ligase, 
transcript variant X1 2.1 2.5 
Ppm1d 
protein phosphatase, Mg2+/Mn2+ dependent, 1D, 
transcript variant X2 1.6 1.7 
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Figure 4.6: Temperature sensitive cell cycle related genes. A) Cyclin-dependent kinase 
inhibitors and B) Cyclins represent the temperature sensitive cell cycle genes in both 
CHO cell lines. 
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4.4.4 Impact of temperature on apoptosis-related genes 
 As mentioned earlier, one of the major reasons to culture CHO cells under low 
temperature condition is to delay the onset of apoptosis and consequently prolong culture 
duration. Apoptosis generally occurs through two different pathways – an extrinsic 
pathway (death receptor) or an intrinsic pathway (mitochondria-mediated) (Arden and 
Betenbaugh 2004; Miura, et al. 2012; Wong, et al. 2006). To investigate the impact of 
low temperature on apoptosis, the genes that were commonly affected in both CHO cells 
were compared to the 84 apoptosis pathway related genes compiled by SABiosciences 
(Dutta et al. 2012, Mao et al. 2010, Ripka et al. 2010). Of the 84 apoptosis related genes, 
there were nine temperature sensitive genes with greater than 1.5-fold change in 
expression (Table 4.6). All the nine genes had increase in expression in both rCHO DP-
12 and CHO DHFR- at lower culture temperature relative to the control culture 
temperature. Interestingly, the nine genes consisted of several apoptotic genes such as 
caspase 3 (Casp3), caspase 6 (Casp6), and Bcl2-associated X protein (Bax), and a few 
anti-apoptotic genes such as nuclear protein 3 (Nol3) and activating transcription factor 5 
(Atf5). Caspases - Casp3 and Casp6 are known as executor caspases, that function in the 
final steps of apoptosis to complete cell death. Nol3 is an anti-apoptosis protein that has 
been shown to down-regulate the enzyme activities of caspases including caspase 8. 
Interestingly, Casp8, one of the initiators of apoptotic cell death, had a decrease in 
expression at lower culture temperature in both CHO cells. The observed levels of 
expression of pro-apoptosis/anti-apoptosis proteins may not necessarily be enough to 
exert an influence on apoptosis. The samples for RNA were harvested from the mid-
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exponential growth phase; however the occurrence of apoptosis is generally observed at a 
much later phase in the process. 
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Table 4.6 - Apoptosis genes with more than 1.5-fold change that were temperature 
sensitive in both rCHO DP-12 and CHO K1-PF 
Fold Change 
Gene 
symbol Gene Description rCHO DP-12 CHO K1-PF 
Apaf1 
apoptotic peptidase activating factor 1, 
transcript variant X3 2.0 2.6 
Atf5 
activating transcription factor 5, 
transcript variant X2 2.5 2.1 
Bax BCL2-Associated X Protein 2.2 2.2 
Bcl2l11 
BCL2-like 11 (apoptosis facilitator), 
transcript variant X1 1.8 1.9 
Casp3 Caspase 3 2.0 1.8 
Casp6 
caspase 6, apoptosis-related cysteine 
peptidase, transcript variant X2 1.8 2.5 
Dapk1 
death-associated protein kinase 1, 
transcript variant X2 1.8 3.2 
Fas 
Fas cell surface death receptor, 
transcript variant X4 1.7 2.5 
Nol3 
nucleolar protein 3 (apoptosis repressor 
with CARD domain), transcript variant X1 1.5 1.9 
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4.4.5 Gene ontology enrichment analysis 
To further understand the cellular changes occurring in CHO cells due to culture 
temperature, a gene ontology (GO) enrichment analysis by GOseq bioconductor package 
was used to identify enriched GO terms (Young, et al. 2012). The GO analysis was 
performed for 1,479 genes with GO terms associated out of the 3186 genes. GO terms 
with 5 or more genes in category were considered as the major GO terms. The 
significantly enriched GO terms included DNA replication, cellular protein metabolic 
process, translation initiation, regulation of apoptotic process and metabolic processes  (p 
≤ 0.05) (Table 4.7).   
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Table 4.7 - Enriched GO terms among the common temperature sensitive genes in rCHO 
DP-12 and CHO K1-PF (FDR ≤ 0.01) 
Go Term Category 
p-value for 
Over-
representation 
Number of 
Genes in 
Category 
Effected 
Number of 
Genes in 
Category 
Cellular process GO:0009987 0.019 6 12 
Cellular protein 
metabolic process GO:0044267 0.000 10 14 
Chromatin assembly or 
disassembly GO:0006333 0.003 10 20 
DNA metabolic process GO:0006259 0.037 6 14 
DNA repair GO:0006281 0.002 16 41 
DNA replication GO:0006260 0.010 15 40 
Metabolic process GO:0008152 0.035 85 383 
Nucleobase-containing 
compound metabolic 
process GO:0006139 0.034 10 28 
Regulation of apoptotic 
process GO:0042981 0.032 9 26 
Translational initiation GO:0006413 0.013 6 15 
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The majority of the enriched DNA replication, cellular protein metabolic process 
and translation initiation genes had lower expression at 33°C relative to 37°C in both 
CHO cells. There were 15 DNA replication genes enriched, with 13 of the 15 genes had 
lower expression in both CHO cells cultured at 33°C. Five of the 15 genes had over 1.5-
fold change in expression at lower temperature in both CHO cell lines – Mcm3, Mcm5, 
Pold1, Pold2, and Polq. DNA polymerases play critical roles in synthesizing DNA, DNA 
repair, DNA recombination and bypassing DNA damage. The classical eukaryote DNA 
polymerases –polymerase delta (Pold1, Pold2), which belong to the family B 
polymerases, are involved with nuclear DNA replication(Hübscher, et al. 2002). 
Polymerase theta (Polq) is a novel DNA polymerase that belongs to family A 
polymerases. Polymerase theta is hypothesized to play a role in DNA repair of inter-
strand cross-links, but the mechanism is not clearly known (Hübscher, et al. 2002). The 
decrease in the expression of DNA polymerases and mini-chromosome complexes genes 
in 33°C cultures compared to 37°C cultures can be related to the observed decrease in 
cell proliferation and growth rate at 33°C cultures. Other GO terms enriched included 
translation and cellular protein metabolic process. There were 6 translation genes that 
were enriched, out of which 5 translation genes had lower expression in both cell lines at 
33°C relative to 37°C. Additionally, 9 of the 10 cellular protein metabolic process genes 
had lower expression. The genes belonged to the TCP1 complex and a heat shock protein 
60, Hspd1 gene, was also included. These genes are involved in the protein folding 
machinery of ER. The decrease in the expression of translation initiation genes and the 
protein folding genes enriched among the cellular protein metabolic process is directly 
113 
 
related to the decrease in global protein synthesis observed for CHO cells cultured at low 
temperature (Masterton and Smales 2014).  
The majority of the genes, six out of nine, belonging regulation of apoptosis GO 
term had higher expression at 33°C relative to 37°C in both CHO cells. Interestingly, 
several of these genes were pro-apoptotic genes such as Bcl2l1, Bcl2l2, Nod1 and Nod2 – 
all of which had increase in expression at 33°C relative to 37°C. These enriched pro-
apoptosis genes could play a critical role in the observed delay in the onset of apoptosis 
under low temperature cultivation (Kaufmann, et al. 1999; Moore, et al. 1997; Trummer, 
et al. 2006). Through the GO enrichment analysis, genes that were enriched among the 
common temperature sensitive genes in rCHO DP-12 and CHO K1-PF were identified. 
Through the enriched GO terms, several genes related to critical processes such as 
apoptosis, protein folding, translation and DNA replication were identified. These genes 
could serve as targets for transferring the benefits of low culture temperature cultivation 
to control culture conditions. 
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4.5 Conclusions 
  Temperature and pH are two important process parameters that are closely 
monitored and maintained for a successful CHO cell culture. In biopharmaceutical 
industries, lower culture temperatures have been applied in order to improve recombinant 
protein productivity and protein quality. The impact of low temperature has been highly 
variable and sometimes, dependent on the CHO cell line used. Similarly, low culture pH 
has been observed to reduce toxic metabolite build-up and improve protein expression 
rates. In this study, a whole-transcriptome sequencing was performed using RNA-Seq on 
two CHO cell lines, rCHO DP-12 and CHO K1-PF, to observed the impact of low 
temperature and pH. The initial pairwise comparisons indicated that the differences in 
gene expression due to pH were minimal and confounded with type-I error. Due to the 
minimal impact of pH on CHO cell transcriptome in this study, the RNA-Seq analysis 
was performed with temperature and cell type as the two factors. In total, there were 
3,186 common genes that were temperature sensitive in both rCHO DP-12 and CHO K1-
PF. The common gene list was used for functional analysis of gene such as glycosylation, 
apoptosis and cell cycle genes. Glycosylation genes that were commonly impacted by 
temperature in both CHO cell lines were Neuraminidase 2 (Neu2), Solute carrier family 
35 members - d1 (Slc35d1) and d2 (Slc35d2). The decrease in Neu2 expression could 
decrease the susceptibility of glycoprotein degradation by sialidases, which could benefit 
IgG based anti-inflammatory therapeutics. Slc35d1 transports UDP-glucuronic acid 
(UDP-GlcA) and UDP-N-Acetylgalactosamine (UDP-GalNAc), while Slc35d2 is known 
to transport UDP-N-Acetylglucosamine (UDP-GlcNAc). The increase in nucleotide sugar 
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substrates in the ER/Golgi can directly improve protein glycosylation. Among the cell 
cycle genes, higher expression of cyclin-dependent kinase inhibitor 1a and lower 
expression of cyclins Ccna2 and Ccnb1 could be key genes involved in the observed slow 
growth rates and cellular proliferation at low temperatures. GO terms related to key 
biological processes such as DNA replication, protein metabolic processes, translation 
and regulation of apoptosis were found to be enriched among the temperature sensitive 
genes. Genes representing DNA replication and translation had lower expression in both 
CHO cell lines cultured at 33°C relative to 37°C, these genes represent the decrease in 
cellular proliferation and global protein synthesis observed at low temperatures. Several 
pro-apoptotic genes such as Bcl2l1 and Bcl2l2 had increase in expression in CHO cells 
cultured at low temperatures. These genes might be critical in improving the apoptotic 
resistance of CHO cells under low temperatures. Overall, the gene expression profiles of 
rCHO DP-12 and CHO K1-PF was characterized to understand the impact of temperature 
at the gene expression level. 
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CHAPTER FIVE 
ASSESSING THE IMPACT OF EXCESSIVE MEDIA GLUCOSE 
CONCENTRATIONS ON RECOMBINANT CHINESE HAMSTER OVARY (CHO) 
CELL TRANSCRIPTOME USING RNA-SEQ 
 
5.1 Abstract 
Chinese hamster ovary (CHO) cells have been used for over 25 years in the 
biopharmaceutical industry to produce recombinant therapeutics, where CHO cells 
produce almost one in three of the manufactured recombinant therapeutics. CHO cells 
offer several advantages over other cell lines, yet the protein titers are only 5-10 g/L, 
leading to high market prices. A limited system-level understanding of CHO cells and the 
effects of process variables on these cells hinder productivity enhancement efforts. The 
recent establishment of genomes sequences for CHO-K1 cell line and Chinese hamster 
organism provide sound platforms to support ‘omics based studies, such as 
transcriptomics. The information obtained from comprehensive transcriptome analysis 
can be leveraged to engineer CHO cells with desired phenotypes including high protein 
titers and used to control the bioreactor environment to reduce waste production. For 
most mammalian cell lines, glucose serves as the primary carbon source required for 
growth and maintenance. Glucose metabolism is also central to several key intermediates 
for the synthesis of cellular components such as lipids, sugar chains and nucleic acids are 
generated during glycolysis. However, incomplete oxidation of glucose can lead to 
lactate production and inefficient low energy. Typically, mammalian cell culture media 
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contain high glucose concentrations that are analogous to diabetic levels of glucose in 
humans, suggesting that the mammalian cells are cultivated in excess glucose. 
Alternatively, maintaining low glucose concentrations (5 mM -10 mM) has been 
attempted to reduce the glucose intake by mammalian cells. The effects of extracellular 
glucose concentration (30 mM or 10 mM) on the transcriptome of rCHO DP-12 cells 
producing monoclonal antibody were investigated. Only 575 genes were identified as 
significantly different (FDR ≤ 0.01). Moreover, gene expression analysis revealed that no 
notable changes in glycolysis, TCA cycle or glycosylation genes were observed in CHO 
cell cultured under different glucose concentrations. These expression studies indicated 
that low glucose concentration batch medium for fed-batch CHO cell cultures has 
potential to improve processes by reducing waste accumulation without impacting 
process related genes. 
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5.2 Introduction 
 CHO cells are widely used in the biopharmaceutical industry, particularly in the 
manufacture of several recombinant protein therapeutics including antibodies, 
interferons, blood factors and growth factors (Butler and Meneses-Acosta 2012; Datta, et 
al. 2013; Kantardjieff and Zhou 2013; Omasa, et al. 2010). It is estimated that more than 
60% of the recombinant protein therapeutics are manufactured using CHO cells, 
accounting for more than $100 billion in global revenues (Bandaranayake and Almo 
2013; Jayapal, et al. 2007; Kantardjieff and Zhou 2013). Despite the availability of 
several mammalian cell line options, the selection of CHO cells as production host is due 
to several advantages offered by it including easy scale up to large-scale processes, well-
developed transfection systems for easy recombinant protein expression and the ability to 
produce human-compatible proteins with proper post-translational modifications (Kim, et 
al. 2012; Omasa, et al. 2010; Wuest, et al. 2012). 
For most mammalian cell lines, glucose serves as the primary carbon source 
required for growth and cell maintenance. Additionally, glucose metabolism is central to 
several key intermediates for the synthesis of cellular components such as amino acids, 
fatty acids, and nucleic acids (Ozturk and Hu 2005). Typically, mammalian cell culture 
media contains glucose concentrations ranging from 25 mM to 35 mM glucose (~4.5 g/L 
to 6.5 g/L). The medial glucose concentrations above 10 mM glucose are analogous to 
diabetic levels of glucose in humans, suggesting that most mammalian cell cultures 
experience high glucose exposure (American Diabetes Association 2008). Glucose 
concentrations have been reported to affect several aspects of cell culture including 
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growth rates, glucose consumption rate and oxygen uptake rate (Lee et al., Meuwly et al, 
Lu et al.). CHO cell metabolism under high glucose concentrations is characterized by 
high glucose uptake rates, followed by incomplete oxidation leading to high lactate 
secretion even in the presence of plentiful of oxygen; a phenomenon known as Warburg 
effect/aerobic glycolysis (Mulukutla et al., Neerman 1996, Lao 1997). Lactate, which is 
considered a metabolic waste by-product, has long been observed to have adverse effects 
on mammalian cell growth, protein production and quality (Lao 1997, Ozturk 1992, Hu 
1987, Omasa 1992). Additionally, it has been recently observed that chronic exposure to 
high glucose concentrations has been observed to alter expression in genes related to 
apoptosis, cellular organization and signal transduction in insulin-producing mouse 
embryonic stem cells (Yee et al. 2012). Several approaches to limit lactate production 
have included substituting glucose with alternate carbon sources such as galactose or 
applying a sophisticated glucose feeding mechanism based on pH measurements 
(Altamirano 2000, 2006, Gagnon et al.). Alternatively, maintaining low glucose 
concentrations (~ 5mM) has been attempted through programmed feeding or fed-batch 
cultures to effectively reduce the glucose intake by mammalian cells and subsequently 
lowering lactate production (Hayter 1992, Hu et al. 1988, Zhou et al. 1995). Moreover in 
a separate study, low glucose concentrations (~1 mM or above) exerted little change on 
CHO cell intracellular metabolites including ATP levels, amino acids and organic acids 
involved in TCA cycle (Lu, et al. 2005). However, understanding gene expression 
changes in CHO cells at low glucose concentrations is necessary to optimize and control 
the process.  
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In this study, the impact of the extracellular glucose concentration on the CHO 
cell transcriptome was investigated using next-generation transcriptomic technique RNA-
Seq. The recombinant CHO cell line, rCHO DP-12, was used that produces a monoclonal 
antibody IgG1 against interleukin-8. Transcriptome profiles of rCHO DP-12 cells cultured 
at two initial glucose concentrations – 30 mM glucose and 10 mM glucose were 
compared representing the higher and low glucose concentrations respectively.  
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5.3 Materials and Methods 
5.3.1 CHO Cell Line and Culture Conditions 
 rCHO DP-12, clone #1934 (ATCC® CRL-12445™) cells were purchased from the 
American Type Culture Collection (ATCC). The rCHO DP-12 cells express a human 
monoclonal antibody (IgG1) against Interluekin-8 (IL-8). The CHO cells were grown in a 
mixture of 80% DMEM, with no added glucose (Life technologies, NY, USA) and 20% 
CD CHO medium (Life technologies, NY, USA) supplemented with Cell-Ess® serum 
replacement (Essential pharmaceuticals LLC, NJ, USA) and 5 mM L-glutamine (Life 
Technologies, NY, USA). A 1 M glucose stock solution was prepared by mixing 
anhydrous dextrose (EMD Millipore, MA, USA) in Millipore water and was filter 
sterilized using 0.2 μm Fisherbrand™ syringe filters. The glucose stock solution was used 
to adjust the initial glucose concentration to 10mM or 30 mM glucose in the 80:20 
DMEM:CD CHO media mixture. rCHO DP-12 cells were preconditioned to the initial 
glucose concentration for at least three passages prior to the experiment. Cells were 
seeded at approximately 2 X 105 cells/mL in 75 cm2 flasks (Corning Inc, NY, USA) and 
incubated at 37°C in humidified 5% CO2 and shaken at 120 rpm. Anti-clumping agent 
(Life technologies, NY, USA) was added (1:250) to the medium prevent cell clumping.  
Cell concentration and viabilities, glucose and lactate concentrations were obtained every 
12 hours. Cell concentrations and viabilities were measured using Bio-Rad TC20™ 
Automated Cell Counter (Bio-Rad Laboratories, CA, USA). Glucose and lactate 
concentrations were obtained using a Yellow Springs Instruments (YSI) 2900 
Biochemistry Analyzer (Yellow Springs, OH, USA). All conditions were conducted in 
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duplicates. Statistical analysis on the growth rates of different conditions were performed 
using JMP (SAS Institute, NC, USA). 
 
5.3.2 RNA Isolation 
For transcriptome analysis, RNA samples were extracted 36 hours after 
inoculating the cells, while the cells were in mid-exponential growth phase. To collect 
mRNA samples, RNAprotect® cell reagent (Qiagen, Valecia, CA) was added to a 
harvested sample immediately upon withdrawal from the flask. Total RNA extraction 
was performed as per RNeasy Plus Mini kit (Qiagen) protocol. Total RNA was extracted 
into 1.5 mL RNAase-Free, DNAase-Free tubes and stored in -80°C until required. A 
NanoDrop 8000 UV-Vis spectrophotometer (Thermo Scientific, MA, USA) and Agilent 
2100 Bioanalyzer System (Agilent, Santa Clara, CA) with RNA 6000 Nano kit (Aglient) 
were used to confirm the quality of the extracted total RNA samples. All samples had 
RNA integrity numbers (RIN) values of greater than nine.   
 
5.3.3 Library Synthesis, Sequencing and Reference Mapping 
The cDNA libraries for whole transcriptome sequencing for each sample were 
constructed by following the recommended protocol of the TruSeq RNA sample 
preparation v2.0 kit (Illumina, San Diego, CA). Briefly, messenger RNA (mRNA) was 
enriched from total RNA using poly-T magnetic beads. Next, mRNA was cleaved into 
fragments by a non-specfic RNA endonuclease and the fragmentation products were 
synthesized into complementary DNA (cDNA) using reverse transcriptase and DNA 
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polymerase enzymes, respectively. The cDNA products then underwent end repair 
process to flush, A-tail, and phosphorylate the DNA ends. These products were ligated to 
adapters that serve as priming sites for enrichment by PCR to create the cDNA libraries 
for sequencing. Each library contains an individual specific DNA index that is used for 
multiplexing during massively parallel sequencing. The resulting cDNA libraries were 
quality validated on an Agilent 2100 Bioanalyzer System to ensure proper fragment 
distribution (~260 bp) and effective removal of adapter dimers. Sequence libraries were 
multiplexed and sequence data collected on 2 lanes of a HiSeq 2500 (Illumina, San 
Diego, CA) at the Genomics division of David H. Murdock Research Institute 
(Kannapolis, NC) using a 2×101 bp, paired end read type. Raw sequence reads were 
demultiplexed on the instrument and reads greater than or equal to 36 bp were cleaned of 
adapter and low quality bases (less than Phred 15) with the Trimmomatic software 
package (Bolger, et al. 2014). 
The trimmed reads obtained were mapped on to the Chinese hamster reference 
genome sequence (RefSeq AMDS00000000, AMDS01000000) with the Subread Aligner 
(v1.4.5) (Liao, et al. 2013b). Subread performed local alignment of the reads and reported 
the locations that have the largest overlap among the reads. FeatureCounts was used to 
assign the reads to the target genes and summarize the data into a read counts table(Liao, 
et al. 2013a). This table was subsequently used as input in the differential gene 
expression analysis.   
 
5.3.4 Differential Gene Expression Analysis and Gene Ontology Analysis 
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Differential gene expression analysis of the RNA-Seq data used the edgeR 
software package for data filtering and statistical analysis (Robinson et al., 2010). edgeR 
utilizes a negative binomial distribution model to capture the quadratic mean-variance 
relationship common to RNA-Seq data (Robinson and smyth 2007, Chen 2014, Robinson 
and smyth 2008). Additionally, edgeR employs an empirical Bayes method to stabilize 
over-dispersion across genes by sharing information across all observations including 
replicates (Robinson 2010, Fong 2012, McCarthy 2012). The steps used for RNA-Seq 
statistical analysis were a) filtering low expressed genes, b) normalizing the library sizes, 
c) visualizing the multidimensional scaling plots, d) estimating dispersions across genes, 
e) conducting exact tests to identify differentially expressed genes and f) performing the 
overrepresentation analysis using GOseq. For filtering the low expressed genes, a gene 
was retained for statistical analysis if the count-per-million (cpm) value was greater than 
1.0 in at least two samples (Anders 2013). To normalize the library sizes, all of the 
samples were normalized using the trimmed mean of M-values (TMM) method in edgeR 
(Robinson and Oshlack 2010). A multidimensional scaling (MDS) algorithm in edgeR 
was used to visualize the similarities and dissimilarities between the samples (Appendix 
B.4) (Robinson and Oshlack 2010). Tagwise dispersions were estimated for the design 
matrix using the quantile-adjusted conditional maximum likelihood (qCML) method 
(McCarthy 2012). Genes with differential expression due to the glucose concentration 
were identified using an exact test, similar to fisher’s exact test (Robinson and smyth 
2008). P-values were adjusted to control the false discovery rate by a Benjamini-
Hochberg procedure and genes with FDR ≤ 0.01 were deemed as statistically significant, 
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unless otherwise specified (Benjamini 2001). Gene ontology enrichment analysis was 
performed using goseq software – a R based Bioconductor package (Young, et al. 2012). 
GOseq accounts for selection bias for long and overexpressed gene sequences by 
calculating the Probability Weighting Function (PWF) (Oshlack and wakefield 2009). 
For GO analysis, goseq uses two vectors – one containing all the measured genes and the 
other containing the differentially expressed genes. Additional information containing 
genes length and the GO categories associated with the genes were supplied. GO terms 
with p ≤ 0.05 from the over-representation test were considered to be statistically 
significant. Additionally, manual screening of gene and gene families, that had common 
stem in its gene symbol, with greater than 1.5-fold expression change was performed to 
identify genes sensitive to serum-free medium adaptation process. 
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5.4 Results and Discussion 
 The rCHO DP-12 cells were seeded into the media containing high and low initial 
glucose concentrations in T-75 flasks at ~ 2 X 105 cells/ mL to allow cultures to grow 
exponentially and to have minimal lactate buildup. It was desired to have a chemically 
defined, serum-free, animal-free, protein-free medium for this study; however it was too 
expensive for such a small experiment to have a custom CD CHO medium formulated 
with low glucose. So an alternative was designed based on DMEM medium with a serum 
replacement supplemented with 20% CD CHO medium, in order to reduce adaptation 
timelines. The cell, glucose, and lactate concentration profiles for the two conditions are 
shown in Figure 5.1.  
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Figure 5.1: Cell concentration (A), glucose (circles) and lactate profiles (squares) are 
shown for CHO cells cultured under high glucose (closed symbol) and low glucose (open 
symbol) conditions. Black arrows indicate time of RNA harvest.  
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As expected, the specific growth rates were not significantly different (P < 0.05) 
for the cultures with initial concentrations of 10 mM and 30 mM glucose over the first 36 
hours, while both cultures had above 2 mM glucose (Li et al.). To characterize the impact 
of the initial glucose concentration on the transcriptome of CHO cells transcriptome, 
RNA was extracted from parallel cultures in mid-exponential phase where glucose 
concentration was the only major difference between the cultures. Specifically, one set of 
cultures had started at 30 mM glucose and had reached 23.4 ± 0.9 mM glucose and the 
other set of cultures had started at 10 mM glucose and reached 4.9 ± 0.1 mM glucose. 
Additionally, the lactate concentrations were 12.2 ± 0.3 mM and 11.6 ± 0.4 mM for high 
and low glucose conditions respectively and were not statistically different (P < 0.05). 
Correspondingly, the glucose consumption rates and lactate production rates were at 36-
hour time point were not different. In contrast, after 36-hours, when the glucose 
concentration in the low glucose cultures dropped below 5 mM glucose, the glucose 
consumption rates and lactate production rates were different, as expected (P < 0.05).  
 
5.4.1 RNA-Seq analysis of glucose concentrations on CHO cell transcriptome 
RNA-Seq data obtained from HiSeq 2500 was assembled and aligned with the aid 
of Chinese hamster reference genome (Lewis et al. 2013). Overall, 27,629 genes mapped 
to the Chinese hamster genome. Differential gene expression analysis was carried as per 
the procedure detailed in materials and methods. Of the 27,629 genes, only 10,090 genes 
were expressed based on the filtering criteria used. An exact test was performed on the 
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10,090 genes to identify which genes had differential expression due to glucose 
concentrations, and only 575 genes were identified as significantly different (FDR ≤ 
0.01). Of the 575 genes identified as sensitive to the glucose concentration, around 60% 
of the genes had lower expression in CHO cells cultured in low glucose medium. Of the 
575 genes, 116 of these genes (~20%) had gene symbols beginning with ‘LOC’ genes, 
meaning that the functional characteristics of these genes are uncertain. It should be noted 
that only 216 genes had 1.5-fold or greater difference in expression level between the two 
culture conditions. Furthermore, 283 genes of the 575 significant genes had gene 
ontology terms associated with it. Gene ontology (GO) enrichment analysis using GOseq 
biconductor package was used to identify biological processes that are over-represented 
among the significant genes. The enriched GO terms with five or more genes in its 
category are shown in Table 5.1. Genes related to immune response, oxidation-reduction 
process and protein transport were enriched among the glucose sensitive genes. The 
immune response GO term was represented by chemokines (Tnfsf9 and Cxcl3) that 
induce proliferation and attract neutrophils, cytokines (Lif) and genes with antiviral 
activity. The exact mechanisms through which these genes are related to external glucose 
concentrations need to be further evaluated. Oxidation-reduction process had 12 genes 
enriched among the glucose sensitive genes. The oxidation-reduction genes had an 
overall trend of decrease in expression, as 9 out of the 12 genes had lower expression in 
rCHO DP-12 cells cultivated at low glucose medium. These genes belonged to several 
different families involved in oxidation-reduction reactions such as reductase, oxygenase 
and dehydrogenase. One possible explanation for the trend of these genes could be that 
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the cells under low glucose concentration experienced low/no oxidative stress. Several 
studies have documented the induction of oxidative stress in response to high glucose 
exposure (Chang, et al. 2003; Giugliano, et al. 1996; King and Loeken 2004). The 
decrease in expression of oxido-reductase genes in CHO cells grown in low glucose 
medium could possibly indicate that the oxidative stress might be lower with lower 
glucose concentration. The reduced oxidative stress could be beneficial to the cells as 
oxidative stress results in the production of reactive oxygen species that cause damages to 
the cell including DNA damage. The protein transport GO term was represented by nine 
genes, eight of which had decrease in expression in rCHO DP-12 cells in lower glucose 
medium. Moreover, of the 9 genes, only 3 genes had over 1.5-fold change in expression. 
Several of the genes belonged to RAS oncogene family or were related to it. Specifically, 
several of these genes are involved in the regulation of intracellular transport and 
formation of transport vesicles, mainly between ER and trans-Golgi network (Stenmark 
and Olkkonen 2001). Rab14, along with other RAS oncogene genes, has been implicated 
in regulating different steps of GLUT sorting (Leto and Saltiel 2012). However, the 
relationship between the protein transport genes and external glucose concentration could 
not be effectively understood and needs to be further investigated.  
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Figure 5.2: Distribution of significant glucose sensitive genes in rCHO DP-12. About 
two-thirds of the genes had known functions and a third of the genes were not 
functionally annotated.  
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Table 5.1 - Enriched significant genes in CHO cells cultured in low glucose medium (FDR ≤ 0.01) 
Gene 
Symbol 
Gene Description Fold-
change 
GO Terms Associated 
immune response (GO:0006955) 
Cxcl3 Chemokine (C-X-C Motif) Ligand 3 1.3 GO:0005576, GO:0005125, 
GO:0008009, GO:0006955 
Lif Luekimia inhibitory factor -1.3 GO:0005576, GO:0005125, 
GO:0006955 
Oasl 2'-5'-oligoadenylate synthetase-like -2.6 GO:0003723, GO:0005524, 
GO:0016740, GO:0006955 
Tinagl1 tubulointerstitial nephritis antigen-like 
1, transcript variant X2 
-2.3 GO:0005044, GO:0008234, 
GO:0030247, GO:0006508, 
GO:0006955 
Tnfsf9 tumor necrosis factor (ligand) 
superfamily, member 9 
1.3 GO:0016020, GO:0005164, 
GO:0006955 
oxidation-reduction process (GO:0055114) 
Acad9 acyl-CoA dehydrogenase family, 
member 9 
1.3 GO:0003995, GO:0016627, 
GO:0008152, GO:0055114 
Adh7 alcohol dehydrogenase 7 (class IV), 
mu or sigma polypeptide, transcript 
variant X2 
-2.5 GO:0003824, GO:0005488, 
GO:0008270, GO:0016491, 
GO:0008152, GO:0055114 
Akr1e2 aldo-keto reductase family 1, member 
E2, transcript variant X1 
-1.5 GO:0016491, GO:0055114 
Cbr3 Carbonyl Reductase 3 -1.4 GO:0003824, GO:0005488, 
GO:0016491, GO:0008152, 
GO:0055114,  GO:0003824, 
GO:0005488, GO:0016491, 
GO:0008152 
Fmo4 flavin containing monooxygenase 4, 
transcript variant X1 
-1.5 GO:0004499, GO:0050660, 
GO:0050661, GO:0055114 
Hmox1 heme oxygenase (decycling) 1, 
transcript variant X2 
-1.3 GO:0004392, GO:0006788, 
GO:0055114 
Idh3b isocitrate dehydrogenase 3 (NAD+) 
beta, transcript variant X1 
-1.4 GO:0000287, GO:0016616, 
GO:0051287, GO:0055114 
Kcnab2 potassium voltage-gated channel, 
shaker-related subfamily, beta member 
2, transcript variant X3 
1.7 GO:0016491, GO:0055114 
Leprel1 leprecan-like 1, transcript variant X2 -1.6 GO:0005506, GO:0016491, 
GO:0016705, GO:0031418, 
GO:0055114 
Ptgr1 prostaglandin reductase 1, transcript 
variant X2 
-1.5 GO:0003824, GO:0005488, 
GO:0008270, GO:0016491, 
GO:0008152, GO:0055114 
Ptgs2 prostaglandin-endoperoxide synthase 
2 (prostaglandin G/H synthase and 
cyclooxygenase), transcript variant X3 
-1.6 GO:0004601, GO:0020037, 
GO:0006979, GO:0055114 
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Table 5.1 - Enriched significant genes in CHO cells cultured in low glucose medium (FDR ≤ 
0.01) 
Xdh xanthine dehydrogenase, transcript 
variant X2 
1.4 GO:0003824, GO:0009055, 
GO:0016491, GO:0046872, 
GO:0050660, GO:0051536, 
GO:0055114 
protein transport (GO:0015031) 
Chmp7 charged multivesicular body protein 7, 
transcript variant X2 
-1.2 GO:0015031 
Gem GTP binding protein overexpressed in 
skeletal muscle, transcript variant X2 
-1.7 GO:0005622, GO:0016020, 
GO:0003924, GO:0005525, 
GO:0007165, GO:0007264, 
GO:0015031 
Rab11fip5 RAB11 family interacting protein 5 
(class I), transcript variant X2 
-1.5 GO:0016020, GO:0043231, 
GO:0008324, GO:0006812, 
GO:0015031, GO:0055085 
Rab14 RAB14, member RAS oncogene 
family, transcript variant X2 
1.3 GO:0005622, GO:0003924, 
GO:0005515, GO:0005525, 
GO:0006886, GO:0006913, 
GO:0007165, GO:0007264, 
GO:0015031 
Rab34 RAB34, member RAS oncogene 
family, transcript variant X3 
-1.3 GO:0005622, GO:0003924, 
GO:0005515, GO:0005525, 
GO:0006886, GO:0006913, 
GO:0007165, GO:0007264, 
GO:0015031 
Rab43 RAB43, member RAS oncogene 
family, transcript variant X2 
-1.3 GO:0005622, GO:0003924, 
GO:0005515, GO:0005525, 
GO:0006886, GO:0006913, 
GO:0007165, GO:0007264, 
GO:0015031 
Rab7b RAB7B, member RAS oncogene 
family, transcript variant X2 
-1.4 GO:0005622, GO:0003924, 
GO:0005515, GO:0005525, 
GO:0006886, GO:0006913, 
GO:0007165, GO:0007264, 
GO:0015031 
Rhob ras homolog family member B, 
transcript variant X2 
-1.4 GO:0005622, GO:0005525, 
GO:0007264, GO:0015031 
Rhoq ras homolog family member Q, 
transcript variant X2 
-1.5 GO:0005622, GO:0005525, 
GO:0007264, GO:0015031 
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 Since the GO enrichment analysis was not entirely effective in understanding the 
impact of glucose concentrations on CHO cell transcriptome, top 10 genes with the 
highest and lowest fold-changes were manually screened and further investigated (Table 
5.2). Of the 20 genes, 8 genes were LOC genes i.e. were not functionally annotated. 
Among the remaining genes, none of the genes had functions that were directly related to 
glucose metabolism. Hence a more concentrated approach was taken and the glucose 
sensitive genes were compared to glycolysis and TCA cycle genes. Additionally, the 
glycosylation related genes were also compared to the glucose sensitive genes.  
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Table 5.2: Top glucose sensitive genes with highest and the lowest fold-changes 
Gene symbol Gene Description Fold-
change 
Higher Expression 
Abcb1b ATP-Binding Cassettem Sub-family B, Member 
1 
2.0 
Apobr apolipoprotein B receptor 2.2 
Cd82 CD82 molecule, transcript variant X2 2.0 
Gdpd4 glycerophosphodiester phosphodiesterase 
domain containing 4 
6.2 
Gk glycerol kinase, transcript variant X1 2.4 
LOC100773612 ribosomal protein S6 kinase alpha-2, transcript 
variant X3 
2.3 
LOC103159228 uncharacterized LOC103159228 2.1 
LOC103160604 uncharacterized LOC103160604 2.0 
LOC103161223 uncharacterized LOC103161223, transcript 
variant X4 
2.2 
Trpm8 transient receptor potential cation channel, 
subfamily M, member 8, transcript variant X3 
1.9 
Lower Expression 
Ckb creatine kinase, brain, transcript variant X2 -3.8 
Col12a1 collagen, type XII, alpha 1, transcript variant X3 -3.1 
Ctgf connective tissue growth factor -5.4 
Dsp desmoplakin, transcript variant X2 -3.3 
Epha2 EPH receptor A2, transcript variant X2 -3.0 
LOC100754646 small proline-rich protein 2H, transcript variant 
X2 
-4.3 
LOC100766854 cytochrome P450 4X1 -3.5 
LOC100769145 liver carboxylesterase 4-like, transcript variant 
X1 
-5.1 
LOC103163538 uncharacterized LOC103163538, transcript 
variant X2 
-3.5 
Mmp12 matrix metallopeptidase 12 (macrophage 
elastase), transcript variant X2 
-3.0 
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5.4.2 Glycolysis and TCA cycle Genes 
Glucose is the major carbon and energy source for CHO cells, where glucose is 
processed to energy and metabolic precursors via the glycolysis and tricarboxylic acid 
(TCA) cycle. It would be expected that extracellular glucose concentrations might affect 
the transcription of glycolysis and TCA cycle genes. There are about 81 genes that code 
for key enzymes and transport proteins related to glycolysis and TCA cycle. Of the 81 
genes, 30 genes were filtered out as lowly expressed genes; however most of these genes 
were variants of the major isoforms expressed. Only two glycolysis genes (Pfkfb3 and 
Pgm1) and two TCA cycle genes (Idh3b and Suclg2) had significantly different levels 
between the high and low glucose cultures (FDR ≤ 0.01) (Table 5.3). When the criterion 
was relaxed to FDR ≤ 0.05, two additional genes passed the cutoff; one glycolysis gene 
(Tpi1) and one TCA cycle gene (Pc) (Table 5.3). Among the six significantly glucose 
sensitive genes (FDR ≤ 0.05) belonging to glycolysis and TCA cycle, no gene had greater 
than 1.5-fold change in expression. However, it was interesting to see a decrease in 
expression of Pfkfb3 gene. Pfkfb3 encodes for 6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase 3, a bi-functional enzyme that has kinase activity as well as biphosphatase 
activity directed towards the synthesis and degradation of fructose-2,6-bisphosphate. The 
enzyme, Pfkfb3, acts as a feedback regulator of glycolysis through its inhibition by 
phosphoenol pyruvate (PEP), a downstream intermediate in glycolysis. Elevated Pfkfb3 
expression has been associated with high glycolytic flux in several tumor cells and 
rapidly proliferating cells.  In contrast, reduced levels of Pfkfb3 in mice models have 
observed reduction in glycolysis and more controlled uptake of glucose (Mor, et al. 
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2011). The decrease in expression of Pfkfb3 in CHO cells exposed to low glucose 
medium could result in more controlled glycolysis in CHO cells. However, further 
studies are required to correlate the impact of gene expression at a proteomic or a 
metabolic level. Overall, there were no major changes between the genes involved in 
glycolysis and TCA cycle. This could imply that glucose concentrations do not simply 
control metabolic pathways at gene or DNA level.  
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Table 5.3: Glycolysis and TCA cycle gene expression in rCHO DP-12 cultured in low 
glucose relative to the high glucose medium  
Gene symbol Gene Description 
Fold 
change 
Glycolysis 
Pfkfb3 
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3, 
transcript variant X4 -1.3 
Pgm1 phosphoglucomutase 1, transcript variant X2 -1.3 
Tpi1 (FDR ≤ 
0.05) Triosephosphate Isomerase 1 -1.2 
 
TCA cycle 
Idh3b 
isocitrate dehydrogenase 3 (NAD+) beta, transcript 
variant X1 -1.4 
Pc (FDR ≤ 
0.05) Pyruvate carboxylase 1.3 
Suclg2 
succinate-CoA ligase, GDP-forming, beta subunit, 
transcript variant X2 1.3 
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5.4.3 Glycosylation 
Glycosylation is one of the critical post-translational modifications involving the 
addition of carbohydrate moieties on the nascent protein inside the Golgi apparatus. 
Glycosylation of therapeutic proteins is critical in determining the efficacy, 
immunogenicity and stability of the protein (Walsh and Jefferis 2006). In industries, 
obtaining consistent glycosylation profiles is necessary for regulatory approval. Fan et al. 
(2013) noticed that the balance of glucose and amino acid metabolism is crucial for 
glycosylation of recombinant proteins. In this study, the impact of initial glucose 
concentration on glycosylation was investigated by observing the gene expression levels 
of 266 glycosylation-related genes, previously identified by Xu et al. (2011). When the 
glycosylation genes were compared to the 575 genes that were sensitive to the initial 
glucose concentration in the medium (FDR ≤ 0.01), only six genes had significantly 
differential expression between the high and low glucose cultures (Table 5.4). Of the six 
genes, two genes had more than 1.5-fold change in expression – UDP-glucose 
glycoprotein glucosyltransferase 2 Uggt2 and mannosidase alpha (Man1c1) expression. 
UGGT2 gene encodes for a protein of the ER quality control machinery that is 
capable of sensing incomplete folding of glycoproteins. Specifically, UGGT2 protein 
attaches a single glucose residue to the incompletely folded or the misfolded glycan. This 
enables the misfolded proteins to rebind with calnexin and re-enter the protein folding 
cycle (Dejgaard, et al. 2004). The increased expression of UGGT2 in CHO cells cultured 
in low glucose medium could be beneficial in guiding correct protein folding of the 
recombinant proteins through the ER machinery. In particular, this can reduce the 
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occurrence of protein aggregates due to improper protein folding, thereby improving 
product quality Man1c1 is one of the members of alpha mannosidases family that are 
involved in the trimming of mannoses from N-linked glycosylation inside golgi. The 
lower expression of mannosidases could potentially impact the proportion of high 
mannose structures, which has been known to elicit rapid removal of the therapeutic 
protein from circulation system. However, the other major members of the mannosidases 
family such as Man1a1 and Man1a2 were not significantly impacted by the external 
glucose concentrations. As glycosylation is very important in recombinant protein 
production, no major gene changes related to glycosylation due to glucose concentrations 
would mean that glucose levels could be controlled to lower levels without affecting 
glycosylation appreciably. In fact, the increased expression of UGGT2 gene could 
potentially improve the product quality through correct protein folding. 
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Table 5.4: Protein glycosylation genes that were sensitive to external glucose 
concentration.  
Gene 
Symbol Gene Family Fold Change 
Fuca1 Fucosidases 1.4 
Uggt2 Glucosyltransferases 1.5 
Ext1 HS GlcNAc/GlcA Transferase -1.4 
Man1c1 Mannosidase -1.7 
Neu1 Sialidases -1.4 
St3gal1 Sialyltransferases -1.4 
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5.5 Conclusions 
 Standard cell culture medium has high glucose concentrations (30mM), which 
does adversely affect productivity due to waste product accumulation. These gene 
expression studies demonstrate that no notable glycolysis, TCA or glycosylation gene 
expression changes were observed in CHO cell culture in medium initially containing 30 
mM and 10 mM glucose, yet the potential to reduce lactate accumulation is improved 
with a low initial glucose concentration. Additionally, the ability to have CHO cell enter 
a lactate consumption phase is improved with a lower initial glucose concentration (Luo, 
et al. 2012; Mulukutla, et al. 2012; Zagari, et al. 2013). These expression studies 
indicated that low glucose concentration batch medium for fed-batch CHO cell cultures 
has potential to improve processes by reducing waste accumulation without impacting 
process related genes.   
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CHAPTER SIX 
CONCLUSIONS AND FUTURE WORK 
 In this dissertation work, next-generation transcriptomic technique, RNA-seq, was 
used to characterize the transcriptome of CHO cells under relevant industrial conditions. 
In Chapter 3, the serum-free medium adaptation process of CHO cells was characterized 
to identify critical genes and gene families that are necessary for successful adaptation. 
For example, it was noticed that the gene expression of several antioxidant genes were 
affected in both CHO cells during the adaptation process, indicating that the cells were 
under oxidative stress. In chapter 4, the transcriptome of rCHO DP-12 and CHO DHFR- 
cultivated under low temperature conditions was elucidated. Several key temperature 
sensitive genes related to protein transport, DNA replication, cell cycle and glycosylation 
genes were identified. In Chapter 5, the gene expression differences in rCHO DP-12 cells 
exposed to two different glucose concentrations were quantified. The analysis identified 
minimal differences in gene expression, especially related to glucose metabolism and 
glycosylation, between the two conditions. Overall, the dissertation work provided a 
transcriptome level-understand of CHO cells and identified several critical biomarkers 
related to each industrially related condition studies. Future work should be conducted in 
integrating the vast amounts of gene expression data obtained through this dissertation 
work with metabolomic and proteomic-based data in order to obtain complete system 
level understand of these industrially relevant conditions.   
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Appendix A 
Filtering of RNA-seq raw counts 
 In the differential gene expression analysis of RNA-seq data, an initial 
independent filtering is performed to remove genes with low or no counts. Usually a 
minimum cut-off value of 1 count per million (CPM) is used. However, the 1 cpm criteria 
did not adequately filter the lowly expressed genes, as several of the low expressed genes 
would appear as differentially expressed genes. In this study, we compared the filter 
cutoff of 5 CPM and 10 CPM with 1 CPM to identify the best cut-off criteria to filter the 
low count genes. Specifically, the impact of independent filtering on the results of 
differential gene expression analysis was investigated. The statistical pairwise 
comparison of rCHO DP-12 cultured at 33°C to rCHO DP-12 cells at 37°C was used as 
the case study. The use of CPM 5 as the cutoff resulted in 12,163 genes post-filtering and 
CPM 10 resulted in 11,016 genes post filtering, as opposed to 14,643 genes available 
post-filtering for CPM 1. The ‘expressed’ genes were then used for differential gene 
expression analysis. BCV plots were initially used to visualize the differences between 
the 3 CPM cutoffs (Figure A1). From the figures, it can be clearly seen that the genes 
with low counts had high variation and were effectively removed at higher CPMs (CPM 
5 and CPM 10). Next, the genes that were differentially expressed (> 1.5-fold change) in 
rCHO DP-12 cultured at low temperature for each CPM criteria was used in a Venn 
diagram to see the common genes (FDR ≤ 0.01). Over 65% of the genes were common 
between the three different filtering criteria used (Figure A2). The genes that were not 
common were genes with FDR values close to 0.01 and hence depending on the 
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comparison were either differentially expressed or were just outside the 0.01 FDR cutoff. 
Additionally, the change in number of differentially expressed genes was also compared 
between the different CPM cutoffs used. When GO enrichment analysis was performed 
on the three different sets, most of the GO terms overlapped between the three cutoffs, 
indicating that the results did not change drastically while using higher CPMs cutoff’s 
(Figure A.3). Hence, the CPM 10 was chosen as the criteria for independent filtering of 
low expressed genes. 
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Figure A1: Biological coefficient of variation (BCV) plots for CPM 1, 5, 10 (top to 
bottom) are an effective way to visualize the relationship of variance with expression  
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Figure A2: Venn diagram of differentially expressed genes in rCHO DP-12 at 33°C 
relative to 37°C with more than 1.5-fold cutoff between the three different CPM cutoff. 
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Figure A.3: Venn diagram of enriched GO terms in rCHO DP-12 cultured at low 
temperature at CPM 1, CPM 5, and CPM 10.  
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APPENDIX B 
MDS PLOTS 
 
 
 
Figure B.1: MDS plots representing gene expression profiles of rCHO DP-12 (closed) 
and CHO DHFR- (open) cultured at three different serum concentrations – 10% 
(sqaures), 5% serum (circles) and 0% serum (triangles).  
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Figure B.2: MDS plots representing gene expression profiles of rCHO DP-12 (Squares 
and circles) and CHO K1-PF (triangles and diamonds) cultured at 37°C (circles and 
diamonds, respectively) and 33°C (squares and triangles, respectively) and at pH 6.90 
(closed) and pH 6.70 (open). 
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Figure B.3: MDS plot for gene expression profiles of rCHO DP-12 (closed) and CHO 
K1-PF (open) at 37°C (circles) and 33°C (squares). 
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Figure B.4: MDS plot for gene expression profiles of rCHO DP-12 cells in high glucose 
(open) and low glucose (closed) medium.  
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APPENDIX C 
CORRECTED GLYCOYLSATION GENE LIST 
Table C-1: Corrected Glycosylation gene list 
Gene Symbol Gene Family 
A4GALT Galactosyltransferases 
A4GNT GlcNAc-transferases 
AGA Lysosomal Enzymes 
ALG1 Glucosyltransferases 
ALG11 Mannosyltransferases 
ALG12 Mannosyltransferases 
ALG13 Glucosyltransferases 
ALG14 Glucosyltransferases 
ALG2 Mannosyltransferases 
ALG3 Mannosyltransferases 
ALG5 Glucosyltransferases 
ALG6 Glucosyltransferases 
ALG8 Glucosyltransferases 
ALG9 Mannosyltransferases 
ARSA Arylsulfatases 
ARSB Arylsulfatases 
ARSE Arylsulfatases 
B3GALNT1 Galactosyltransferases 
B3GALNT2 Galactosyltransferases 
B3GALT1 Galactosyltransferases 
B3GALT2 Galactosyltransferases 
B3GALT4 Galactosyltransferases 
B3GALT5 Galactosyltransferases 
B3GALT6 Galactosyltransferases 
B3GAT1 UDP-glucuronosyltransferases 
B3GAT2 UDP-glucuronosyltransferases 
B3GAT3 UDP-glucuronosyltransferases 
B3GNT1 GlcNAc-transferases 
B3GNT2 GlcNAc-transferases 
B3GNT3 GlcNAc-transferases 
B3GNT4 GlcNAc-transferases 
B3GNT5 GlcNAc-transferases 
B3GNT7 GlcNAc-transferases 
B3GNT8 Galactosyltransferases 
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Table C-1: Corrected Glycosylation gene list 
B4GALNT1 GalNAc-transferases 
B4GALNT2 GalNAc-transferases 
B4GALNT3 GalNAc-transferases 
B4GALNT4 GalNAc-transferases 
B4galt1 Galactosyltransferases 
B4GALT2 Galactosyltransferases 
B4GALT3 Galactosyltransferases 
B4GALT4 Galactosyltransferases 
B4GALT5 Galactosyltransferases 
B4GALT6 Galactosyltransferases 
B4GALT7 Galactosyltransferases 
C1GALT1 Galactosyltransferases 
C1GALT1C1 Galactosyltransferases 
CHPF Galactosyltransferases 
CHST1 Sulfotransferases 
CHST10 Sulfotransferases 
CHST11 Sulfotransferases 
CHST12 Sulfotransferases 
CHST13 Sulfotransferases 
CHST14 Sulfotransferases 
Chst15 GalNAc-transferases 
CHST2 Sulfotransferases 
CHST3 Sulfotransferases 
CHST4 Sulfotransferases 
CHST7 Sulfotransferases 
CHST9 Sulfotransferases 
CHSY1 Galactosyltransferases 
CMAS Nucleotide Synthesis  
CSGALNACT1 GalNAc-transferases 
Csgalnact2 GalNAc-transferases 
CTBS Lysosomal Enzymes 
CTSA Lysosomal Enzymes 
DAD1 N-glycans-transferase 
DDOST N-glycans-transferase 
DPAGT1 GlcNAc-transferases 
DPM1 Mannosyltransferases 
DPM3 Mannosyltransferases 
DSEL Sulfotransferases  
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Table C-1: Corrected Glycosylation gene list 
EXT1 HS GlcNAc/GlcA Transferase 
EXT2 HS GlcNAc/GlcA Transferase 
EXTL1 GlcNAc-transferases 
EXTL2 GlcNAc-transferases 
EXTL3 GlcNAc-transferases 
FPGT Nucleotide Synthesis  
FUCA1 Fucosidases 
FUT1 Fucosyltransferases 
FUT10 Fucosyltransferases 
FUT11 Fucosyltransferases 
FUT2 Fucosyltransferases 
FUT4 Fucosyltransferases 
FUT6A Fucosyltransferases 
FUT6B Fucosyltransferases 
FUT7 Fucosyltransferases 
FUT8 Fucosyltransferases 
FUT9 Fucosyltransferases 
GAA Hyaluronoglucosaminidases 
GAL3ST1 Sulfotransferases 
GAL3ST2 Sulfotransferases 
Gal3ST3 Sulfotransferases 
GAL3ST4 Sulfotransferases 
GALC Lysosomal Enzymes 
GALK1 Nucleotide Synthesis  
GALK2 Nucleotide Synthesis  
GALNS Sulfatases 
GALNT1 GalNAc-transferases 
GALNT11 GalNAc-transferases 
GALNT12 GalNAc-transferases 
GALNT13 GalNAc-transferases 
GALNT14 GalNAc-transferases 
GALNT15 GalNAc-transferases 
GALNT16 GalNAc-transferases 
GALNT18 GalNAc-transferases 
GALNT2 GalNAc-transferases 
GALNT3 GalNAc-transferases 
GALNT5 GalNAc-transferases 
GALNT6 GalNAc-transferases 
157 
 
Table C-1: Corrected Glycosylation gene list 
GALNT7 GalNAc-transferases 
GALNT8 GalNAc-transferases 
GALNT9 GalNAc-transferases 
GALT Nucleotide Synthesis  
GBA Lysosomal Enzymes 
GBGT1 GalNAc-transferases 
GCNT1 #N/A 
GCNT3 GlcNAc-transferases 
GCNT4 GlcNAc-transferases 
GFPT2 Nucleotide Synthesis  
GLA Galactosidase 
GLB1 Galactosidase 
GLCE Miscellaneous 
GM2A Lysosomal Enzymes 
GMDS Nucleotide Synthesis  
GMPPA Nucleotide Synthesis  
GMPPB Nucleotide Synthesis  
GNB1 Nucleotide Synthesis  
GNB2L1 Nucleotide Synthesis  
GNE Nucleotide Synthesis  
GNPDA1 Nucleotide Synthesis  
GNPNAT1 Nucleotide Synthesis  
GNS Sulfatases 
GPI Nucleotide Synthesis  
GUSB Galactosidase 
GYLTL1B GlcNAc-transferases 
HAS2 Hyaluronan synthase 
HAS3 Hyaluronan synthase 
HEXA Hexosaminidases 
HK1 Nucleotide Synthesis  
HK3 Nucleotide Synthesis  
HPSE Heparanases 
HPSE2 Heparanases 
HS2ST1 Sulfotransferases 
HS3ST1 Sulfotransferases 
HS3ST2 Sulfotransferases 
HS3ST4 Sulfotransferases 
HS3ST5 Sulfotransferases 
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Table C-1: Corrected Glycosylation gene list 
HS3ST6 Sulfotransferases 
HS6ST1 Sulfotransferases 
HS6ST2 Sulfotransferases 
HS6ST3 Sulfotransferases 
HYAL1 Hyaluronoglucosaminidases 
HYAL2 Hyaluronoglucosaminidases 
HYAL3 Hyaluronoglucosaminidases 
HYAL4 Hyaluronoglucosaminidases 
IDS Sulfatases 
IDUA Iduronidases 
KHK Nucleotide Synthesis  
LARGE GlcNAc-transferases 
LCT Lysosomal Enzymes 
LFNG GlcNAc-transferases 
LIPA Lysosomal Enzymes 
MAN1A1 Mannosidase 
MAN1A2 Mannosidase 
MAN1C1 Mannosidase 
MAN2A1 Mannosidase 
MAN2A2 Mannosidase 
MAN2B1 Mannosidase 
MANBA Mannosidase 
MFNG GlcNAc-transferases 
MGAT1 GlcNAc-transferases 
MGAT2 GlcNAc-transferases 
MGAT3 GlcNAc-transferases 
MGAT4A GlcNAc-transferases 
MGAT4B GlcNAc-transferases 
MGAT5 GlcNAc-transferases 
MGAT5B GlcNAc-transferases 
Mgea5 Hyaluronoglucosaminidases 
MPI Nucleotide Synthesis  
NAGA Lysosomal Enzymes 
NAGK Nucleotide Synthesis  
NAGLU Mannosidases 
NANS Nucleotide Synthesis  
NDST1 Sulfotransferases 
NDST2 Sulfotransferases 
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Table C-1: Corrected Glycosylation gene list 
Neu1 Sialidases 
Neu2 Sialidases 
Neu3 Sialidases 
Neu4 Sialidases 
NPL Mannosidases 
OGT GlcNAc-transferases 
PAPSS1 Nucleotide Synthesis  
PAPSS2 Nucleotide Synthesis  
PGM1 Nucleotide Synthesis  
PIGA GlcNAc-transferases 
PIGC GlcNAc-transferases 
PIGH GlcNAc-transferases 
PIGM Mannosyltransferases 
PIGP GlcNAc-transferases 
PMM2 Nucleotide Synthesis  
POFUT1 Fucosyltransferases 
POFUT2 Fucosyltransferases 
POMGNT1 GlcNAc-transferases 
POMT1 Mannosyltransferases 
POMT2 Mannosyltransferases 
RENBP Nucleotide Synthesis  
RFNG GlcNAc-transferases 
RPN1 N-glycans-transferase 
RPN2 N-glycans-transferase 
SGSH Sulfohydrolases 
SLC35A1 Nuc. Sugars Transporters 
SLC35A2 Nuc. Sugars Transporters 
SLC35A3 Nuc. Sugars Transporters 
SLC35A4 Nuc. Sugars Transporters 
SLC35A5 Nuc. Sugars Transporters 
SLC35B1 Nuc. Sugars Transporters 
SLC35B2 Nuc. Sugars Transporters 
SLC35B3 Nuc. Sugars Transporters 
SLC35B4 Nuc. Sugars Transporters 
SLC35C1 Nuc. Sugars Transporters 
SLC35C2 Nuc. Sugars Transporters 
SLC35D1 Nuc. Sugars Transporters 
SLC35D2 Nuc. Sugars Transporters 
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Table C-1: Corrected Glycosylation gene list 
SLC35D3 Nuc. Sugars Transporters 
SLC35E1 Nuc. Sugars Transporters 
SLC35E3 Nuc. Sugars Transporters 
SLC35E4 Nuc. Sugars Transporters 
SLC35F1 Nuc. Sugars Transporters 
SLC35F2 Nuc. Sugars Transporters 
SLC35F3 Nuc. Sugars Transporters 
SLC35F4 Nuc. Sugars Transporters 
SLC35F5 Nuc. Sugars Transporters 
ST3Gal1 Sialyltransferases 
ST3Gal2 Sialyltransferases 
ST3Gal3 Sialyltransferases 
ST3Gal4 Sialyltransferases 
ST3Gal5 Sialyltransferases 
ST3Gal6 Sialyltransferases 
ST6Gal1 Sialyltransferases 
ST6Gal2 Sialyltransferases 
ST6GalNAc3 Sialyltransferases 
ST6GalNAc4 Sialyltransferases 
ST6GalNAc5 Sialyltransferases 
ST6GalNAc6 Sialyltransferases 
ST8SIA1 Sialyltransferases 
ST8SIA2 Sialyltransferases 
ST8SIA3 Sialyltransferases 
ST8SIA4 Sialyltransferases 
ST8SIA5 Sialyltransferases 
ST8SIA6 Sialyltransferases 
SULF1 Sulfatases 
SULF2 Sulfatases 
TSTA3 Nucleotide Synthesis  
UAP1 Nucleotide Synthesis  
UGCG Glucosyltransferases 
UGGT2 Glucosyltransferases 
UGP2 Nucleotide Synthesis  
UGT2A1 UDP-glucuronosyltransferases 
UST Sulfotransferases 
UXS1 Nucleotide Synthesis  
WBSCR17 GalNAc-transferases 
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Table C-1: Corrected Glycosylation gene list 
XYLT1 Xylosyltransferases 
XYLT2 Xylosyltransferases 
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